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ABSTRACT 
 
MITOCHONDRIAL TARGETING IN PHOTODYNAMIC THERAPY.  
METABOLIC AND DRUG STRUCTURE REQUIREMENTS FOR SPECIFIC 
MITOCHONDRIAL LOCALIZATION.  A PILOT INVESTIGATION.  
 
by 
 
Melissa R. Pergande 
 
The University of Wisconsin-Milwaukee, 2012 
Under the Supervision of Dr. Guilherme L. Indig 
 
 
 
Photodynamic therapy (PTD) has shown promise in the treatment of certain types 
of cancer (Davis et al. 1985, Chen 1988). One appealing strategy under consideration to 
selectively target tumor cells in PDT is that of mitochondrial targeting (Chen 1988, Chen 
1989). The concept of mitochondrial targeting has its origin in the pioneering observation 
by Chen and colleagues that an enhanced mitochondrial transmembrane potential 
(ΔΨmito) is a prevalent tumor cell phenotype (Davis et al. 1985, Chen 1988). Because the 
plasma transmembrane potential is negative on the inner side of the cell, and the 
mitochondrial transmembrane potential is negative on the matrix side of this organelle, a 
variety of extensively conjugated cationinc molecules (i.e., cationic dyes) tend to 
accumulate in energized cell mitochondria with a high degree of specificity. In keeping 
with the larger transmembrane potentials typically observed in tumor cells, a number of 
cationic dyes were already found both to accumulate in larger quantities and be retained 
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for longer periods in the mitochondria of these cells as compared to normal cells (Chen 
1988, Chen 1989). In these last cases, the respective (photo) toxic effects observed 
toward tumor cells were considerably higher than the effects observed toward normal 
cells (Belostotsky et al. 2011). Thus, a differential in dye loading and retention, when 
observed between normal and tumor cells, can provide an opportunity for the selective 
destruction of the latter cells via mitochondrial targeting.      
The rational development of novel PDT agents for mitochondrial targeting is 
currently limited by the lack of a reliable model describing how the molecular structure 
of cationic dyes control the degree of specificity with which these agents localize in 
energized cell mitochondria, and may preferably accumulate in tumor cells as compared 
to normal cells.  Likewise, the reasons why mitochondrial transmembrane potentials are 
typically higher in tumor cells are yet to be understood. The objectives of this project 
were two-fold.  First, to investigate how the molecular structure and charge in a series of 
rhodamine dyes affects their subcellular distribution/mitochondrial localization. Second, 
to explore whether mitochondrial transmembrane potentials may be affected by enhanced 
glutaminolysis when the supply of glucose is limited. To this end, we have used a non-
transformed cell line (CV-1, African green monkey kidney cells) as a biological model. 
Glutaminolysis is an anaplerotic pathway thought to be highly active in tumor cells.  
 Our findings have provided further evidence which support previous inferences 
on the structural requirements for rapid and selective mitochondrial localization. First, the 
PDT agent must be a cationic species at physiological pH. Zwitterionic species do not 
show these desirable properties.  Second, cationic dyes showing lipophilic character 
similar to that of the prototypical mitochondrial marker Rhodamine-123 can be expected 
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to localize in energized cell mitochondria with a high degree of specificity, although such 
specificity is presumably lost when the lipophilic character of the cationic agent is 
significantly higher than that of Rhodamine-123. These studies have also indicated that 
the mitochondrial transmembrane potentials of CV-1 cells apparently increase when these 
cells experience glucose starvation and derive their energy needs primarily from 
glutamine/glutaminolysis.  The observed effects were modest though, and very severe 
morphological abnormalities were simultaneously noticed. Although these results appear 
to represent the first line of evidence on the possibility that the enhanced mitochondrial 
potential typically observed in tumor cells may (at least in part) be a result of enhanced 
glutaminolysis, further investigations will be required in order to better explore such 
possibility. In addition, while the development of a single cell model for use in studies 
dealing with mitochondrial targeting would be highly desirable, e.g., CV-1 cultures 
showing either high or normal mitochondrial potentials as modulated by the 
characteristics of the growth media, the morphological abnormalities observed in this 
study (for cells grown under conditions of glucose starvation) may represent a major 
limitation for the development of such a biological model. 
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1. Introduction 
Cancer is a specific group of diseases that cause normal, healthy cells to transform 
and grow uncontrollably. These normal-to-cancer transitions are thought to be due to 
certain genetic factors or exposure to mutagens. Consequently, this uncontrollable 
cellular growth can cause malignant tumors to develop. Unfortunately, over time many 
of these cellular transitions can become potentially fatal. According to the World Health 
Organization, 7.6 million people worldwide died (13% of all deaths) from cancer in 
2008 (Ferlay et al. 2010). Consequently, certain chemotherapy and anti-cancer drugs 
have been developed that target the most rapidly dividing cells in the body in order to 
slow down the progression of these diseases. Often, this includes both normal and 
transformed cells. Therefore, different therapies that can be used to selectively target and 
kill cancer cells, while sparing the surrounding normal cells, continues to be a topic of 
interest. One such treatment modality that has shown promise is that of mitochondrial 
targeting in Photodynamic therapy.  
 
1.1  Photodynamic Therapy 
Photodynamic therapy (PDT) is the photoinduced destruction of living cells by the 
combined action of three essential components: a PDT agent (photosensitizer) (typically 
a dye showing strong absorption bands in the visible and/or near-infrared regions of the 
spectrum), light, and dissolved molecular oxygen (Khan et al. 1995). This therapeutic 
approach was first scientifically documented by Raab in 1896 when studying the effects 
of acridine on paramecia (algae) cultures (Schastak et al. 2008); however, it was not 
referred to as PDT until much later.  Subsequently, in 1903 Finsen was awarded the 
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Nobel Prize for his work using this therapeutic approach to clinically treat diseases such 
as: lupus, cutaneous tuberculosis, and smallpox lesions (Dolmans et al. 2003). Since the 
pioneering work of the above scientists, the concept of PDT has evolved as a promising 
treatment for cancer. Some of the highlights in this progression include the work of von 
Tappeiner and Jesiokek. Notably, these authors are credited with the very first attempt to 
utilize this method as a clinical treatment for tumors (von Tappeiner and Jesionek 1903, 
Moan and Peng 2003).  Later, in 1960 Lipson and colleagues were able to demonstrate 
that haematoporphyrin derivative (HPD) efficiently localized in tumors and emitted 
fluorescence, thus allowing for the photo detection of certain tumors (Lipson et al. 1961). 
Interestingly, the first successful treatment against cancer (skin) was not documented 
until 1978 when Dougherty and colleagues published results in which 111 of 113 
cutaneous and subcutaneous malignant tumors were observed to be partially or 
completely responsive to this modality of treatment (Dougherty et al. 1978). It was in that 
same year that Kelly and colleagues initiated the first clinical trial of HPD to treat bladder 
cancer (Dolmans et al. 2003). Currently, PDT is still proposed as a method of treatment 
for various types of cancer including the purging of residual tumor cells from autologous 
bone marrow grafts in patients with leukemia, lymphoma, or metastatic neuroblastoma 
(Huang et al. 2003, Bergmann et al. 2008, Kessel and Oleinick 2009). Therefore, the vast 
potential of phototherapy has been known for over a hundred years, but the journey in 
successfully targeting and killing cancer cells has been gradual. 
The therapeutic approach of PDT owes its success to the highly cytotoxic effects 
that are produced by a variety of reactive oxygen species (ROSs). This clinical treatment 
process is initiated by administering a certain photosensitizer into the bloodstream 
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intravenously or topically to the skin depending on the location of the tissue being 
treated. It is important to note that photosensitizers themselves are relatively unactive 
(prodrugs) until activated to their active state. This is done by the use of visible or near 
infrared light, one that is appropriate for exciting the photosensitizer to produce ROSs 
(Soukos et al. 1996). After the absorption of light (photons), the photosensitizer is excited 
from its ground state (S0) to a short-lived excited singlet state (S1, S2, S3, etc) (Figure 
1.1). Notably, Kasha’s rule states that regardless of which singlet state is originally 
generated upon photon absorption (i.e., S1, S2, S3, etc) in condensed media, within just a 
few femtoseconds the population of excited states will be entirely located in the 
respective first electronically excited singlet state (S1) (Kasha 1968). Subsequently, the 
excited photosensitizer can return to its respective ground state (S0) either by emitting a 
photon (fluorescence) or through internal conversion with energy lost as heat. 
Alternatively, the first electronically excited singlet state (S1) can cross, to its respective 
first longer-lived excited triplet state (T1) via intersystem crossing; this involves a change 
in the spin of an electron.  Here, the excited triplet photosensitizer (
3
Sens*) can engage 
either in electron (type I) or energy (type II) transfer reactions (Figure 1.2). The type I 
reaction involves the unidirectional electron transfer between the triplet photosensitizer 
(
3
Sens*) and substrate (S), such as a phospholipid in a cell membrane, to form a radical 
pair which can further react with dissolved molecular oxygen to produce a variety of 
cytotoxic ROSs including: superoxide, hydroxyl, and peroxyl radicals as well as 
hydrogen peroxide (Khan and Wilson 1995). In addition, these ROSs can "dismutate" to 
produce other ROSs (Khan and Wilson 1995). The type II reactions involve the energy 
transfer from  the  triplet  photosensitizer  (
3
Sens*)  to  molecular  oxygen   thus   forming   
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Figure 1.1 Jablonski diagram showing absorption, along with non-radiative (VR, IC and ISC), and 
radiative (fluorescence and phosphorescence) processes of deactivation of electronically excited states 
(VR=vibrational relaxation, IC=internal conversion, ISC=intersystem crossing).                                                 
 
 
 
                                             O2 
3
Sens* + S  Radical Pair   Reactive Oxygen Species Type I 
 
3
Sens* + O2  
1
O2* Type II 
 
 
 
Figure 1.2 Type I and Type II photochemical reactions. 
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the ROS, singlet oxygen (
1
O2*).  This later PDT mechanism regenerates the ground state 
photosensitizer, which can be subsequently used in cycles of photosensitization, and for 
this reason it is thought that type II reactions are more desirable in PDT.  Intuitively, both 
the type I and type II reactions can occur simultaneously (i.e., in competition) in 
biological systems. Interestingly, only cells found in the immediate area of the reaction 
are directly affected due to the short half-lives of the various ROSs produced. For 
example, the half-life of singlet oxygen produced in biological systems is <0.04 µs, and 
its radius of action is <0.02 µm (Moan and Berg 1991). Nonetheless, through both 
mechanisms (type I and type II), PDT is able to induce the desired cytotoxic effects to the 
cells being targeted.          
 Photofrin II (PII) (Figure 1.3) is one of the most extensively used 
photosensitizers employed in PDT for the treatment of cancers due to it high 
accumulation in tumors (Dougherty et al. 1998, Dougherty 1992). It is a purified version 
of an oligomerized hematoporphyrin derivative (Bartlett 2002) which primarily targets 
the destruction of the tumor vasculature via the enhanced permeability and retention 
(EPR) effect rather than by direct cell kill (Maeda 2001). That is, it works by shutting 
down the tumor’s blood supply thereby destroying the vasculature and thus promoting 
destruction to large areas of solid tumors. Although PII is the most commonly used 
photosensitizer to date, it has several limitations and undesirable properties which have 
limited its overall effectiveness. Interestingly, PII and other common photosensitizers are 
highly phototoxic in the presence of molecular oxygen, but do not work well in hypoxic 
areas of solid tumors (Dougherty 1988). In addition, PII and other anionic porphyrins are 
not as effective in the poorly vascularized internal regions of the tumor primarily because  
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Figure 1.3 Molecular structure of Photofrin II (PII). 
 
 
they work by targeting the destruction of the vasculature rather than direct cell kill 
(Bartlett 2002). In addition, porphyrins are not exclusively tumor targeting and display 
long persistence in normal tissues, including the skin. Therefore, patients often need to 
limit their exposure to sunlight after receiving treatment. Lastly, PII has an ideal 
absorption maximum of 630 nm, however, its molar absorption coefficient at this 
wavelength is low (  = 1170 M
-1
cm
-1
) (Dougherty 1992, Stewart et al. 1998).  
Consequently, high concentrations of the photosensitizer and light must be delivered to 
the tumor. Since tumor localization of the photosensitizer is an important factor in the 
overall effectiveness of PDT, there remains an interest in developing novel 
photosensitizers that primarily target tumor cells with increased specificity. One 
appealing strategy under consideration to selectively target tumor cells in PDT is that of 
mitochondrial targeting. 
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1.1.1 Mitochondrial targeting in PDT 
 The concept of mitochondrial targeting has its origin in the pioneering 
observation by Chen and colleagues that an enhanced mitochondrial transmembrane 
potential (ΔΨmito) is a prevalent tumor cell phenotype (Chen 1988, Chen 1989). These 
authors investigated over 200 distinct cell lines (tumor and normal varieties) and 
demonstrated that the mitochondrial transmembrane potential is typically 60 mV higher 
in tumor cells than in normal cells, where only approximately 2% do not show this 
characteristic phenotype (Davis et al. 1985, Chen 1988). In addition, it has been observed 
that certain conjugated cationic molecules, dyes (potential photosensitizers) displaying 
the appropriate structural features, accumulate in the mitochondria of tumor cells with a 
high degree of specificity due to this enhanced transmembrane potential (Belostotsky et 
al. 2011). Notably, these cationic compounds are electrophoretically driven through the 
membranes and localize efficiently in the mitochondria because the plasma 
transmembrane potential is negative on the inner side of the cell and the inner 
mitochondrial transmembrane potential is negative on the matrix side of the organelle. 
Therefore, the idea of the selective targeting and destruction of tumor cells via 
mitochondrial targeting in PDT is based on the observation that a number of cationic dyes 
tend to naturally accumulate in larger amounts and are retained for longer periods in the 
mitochondria of tumor cells compared to normal cells (Bernal et al. 1993, Kandela et al. 
2002).  
The selective accumulation of such suitable cationic molecules may be adequately 
predicted using the Nernst formalism (Figure 1.4). Interestingly, the plasma 
transmembrane potential is typically -60 mV while the mitochondrial transmembrane 
potential is typically -120 mV for normal cells and -180 mV for tumor cells (Chen 1988).  
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 [A+]cytoplasm = [A+]outside the cell × 10
-{ΔΨplasma/(2.3RT/nF)}
 (1) 
[A+]mito = [A+]cytoplasm × 10
-{ΔΨmito/(2.3RT/nF)}
 (2) 
[A+]mito = [A+]outside the cell × 10
-{(ΔΨplasma+ΔΨmito)/(2.3RT/nF)}
 (3) 
 
Figure 1.4 Nernst equations.  ΔΨ plasma represents the plasma transmembrane potential (typically near -60 
mV), ΔΨ mito represents the mitochondrial transmembrane potential (typically –180 mV for tumor cells 
and –120 mV for normal cells), R represents the thermodynamic constant for ideal gases, T the absolute 
temperature, n the valence of the ion crossing the membrane, and F the Faraday constant. For monovalent 
ions, the parameter 2.3 RT/nF assumes the value of ~ 61 mV at 37 
o
C (Belostotsky et al. 2011). 
 
 
Equations 1-3 can be used to calculate the ratio of cationic molecules that could 
potentially accumulate in the mitochondria when employing the same concentration in 
both a tumor and normal cell line (Trapp and Horobin 2005, Belostotsky et al. 2011). 
When using the above numbers, the Nernst formalism predicts that the mitochondria of 
tumor cells can be theoretically loaded with as many as 10 times more of these selective 
molecules. Therefore, in addition to  the  observations  of  Chen   and others  (discussed 
above), the difference in dye loading, as predicted by the classical Nernst formalism, 
reinforces the premise that tumor cells can be selectively targeted with increased 
specificity via mitochondrial targeting and  selective tumor cell kill induced.  
In order for the successful mitochondrial localization of these selected cationic 
dyes to occur, the mechanism of mitochondrial targeting must be the dominant means of  
subcellular distribution. For example, one such mechanism that might preclude 
mitochondrial localization is that of lipophilic partitioning. Reasonably, the lipophilic 
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character of the cationic dye must be low enough that it is unable to compete with the 
mechanism of transmembrane potential-driven mitochondrial localization. If the latter is 
not the case, the increased loading of the cationic dye observed between tumor and 
normal cells, respectively, can be expected to significantly decrease or be entirely lost 
(Belostotsky et al.  2011); consequently, no tumor cell selectivity would be expected to 
occur. Comparatively, staining of other organelles would be expected to take place with 
the same efficiency as well (Indig et al. 2000, Kandela et al. 2002, Kandela et al. 2003, 
Lacerda et al 2005). Therefore, the desired distribution of cationic dyes into the 
mitochondria of tumor cells will be theoretically possible only if the contributions arising 
from the transmembrane potential-driven mechanism are greater than those arising from 
the mechanism of lipophilic partitioning or any other competing subcellular distribution 
mechanism (Belostotsky et al. 2011).  
With this in mind, there are several cationic dyes that are known to naturally 
accumulate in the mitochondria of cells, however, only a small subset of these dyes is 
known to induce the desired photochemical destruction to tumor cells with a high degree 
of specificity (Indig 1999, Morgan et al. 2001). Some of these previously studied dyes 
include cationic triarylmethanes (TAM
+
). For example, Crystal Violet (CV
+
), a relatively 
low toxic dye (Indig 1999), has been employed in a variety of medicinal applications as: 
an antihelmintic, an antiseptic in burn patients, and for treatment of umbilical cords of 
newborns (Duxbury 1993), as well as an antifungal to treat both topical and vaginal 
infections caused by Candida (Remington’s Pharmaceutical Sciences 1990, Bartlett 
2002). Interestingly, it has been demonstrated that CV
+
 localizes in the mitochondria and 
induces the desired phototoxic effects to tumor cells (HT-29) (Kandela et al. 2002). 
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Comparatively, Ethyl Violet (EV
+
) is known to induce cytotoxic effects; however, Indig 
and colleagues demonstrated that it does not induce the destruction of tumor cells with a 
high degree of selectivity because not only does it localize in the mitochondria, but it is 
observed to accumulate in the lysosomes of both normal (CV-1) and tumor (MES-SA) 
cells (Kandela et al. 2002). In this case, any cell death induced by EV
+
 is not primarily 
controlled by mitochondrial damage, rather by a more complex combination of 
subcellular toxic events (Kandela et al. 2002). Remarkably, the studies involving CV
+
 
and EV
+
 are of vast importance because they reveal that only dyes that exclusively 
localize in the mitochondria can mediate the destruction of tumor cells with desirable 
degrees of selectivity. In addition, these authors demonstrated that only dyes showing a 
lipophilic/hydrophilic character similar to that of the prototypical mitochondrial-specific 
dye, Rhodamine-123 (Rh-123), are efficiently taken up by tumor cells in large quantities 
and display selective tumor cell kill.   
Rh-123 is a member of another class of dyes (rhodamines) known to accumulate 
in the mitochondria of cells. It is highly fluorescent and commonly employed as a 
molecular probe in fluorescence microscopy. Also, it was the first dye identified by Chen 
and colleagues as a mitochondrial-specific agent (Summerhayes et al. 1982, Chen 1988, 
Chen 1989).  These authors demonstrated that tumor cells uptake and retain more Rh-123 
longer when compared to normal cells. Presumably, the mechanism of cellular uptake 
and subcellular localization (mitochondrial) of Rh-123 is controlled primarily by 
transmembrane potentials (Chen 1988, Chen 1989) where the dye has been observed to 
pass directly to the mitochondria with no staining of the plasma membrane, nuclear 
envelope, lysosomes, endoplasmic reticulum, or Golgi complex (Johnson et al. 1981). 
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Therefore, Rh-123’s characteristic positive charge most likely allows for easy 
mitochondrial uptake and retention. Interestingly, most lipophilic, cationic molecules are 
toxic to cells due to their increased retention, however, studies of a vast number of 
cationic dyes revealed that Rh-123 specifically showed low cytotoxicity when CV-1 cells 
were grown in a 10 µM solution of the dye for two weeks (Lampidis et al. 1984, Chen 
1988). Therefore, many research studies have demonstrated that Rh-123 is a great choice 
for studying living cells because it is low in cellular toxicity and allows for easy 
visualization using fluorescence microscopy.      
 The most important aspect of mitochondrial targeting, from a therapeutic 
viewpoint in PDT, is the fact that most mitochondrial damage can lead, and often does, to 
apoptosis. Ideally, any potential PDT drug candidate must show the following desirable 
properties to be considered an ideal agent in order to induce such desired effects: (i) 
strong absorption in the visible and near-IR regions of the electromagnetic spectrum, (ii) 
display good yields of triplet formation upon electronic excitation, (iii) effective singlet 
oxygen generation from the respective triplets, (iv) carry a positive charge (cationic 
photosensitizers typically show superior tumor cell selective properties), and (v) display a 
high degree of selectivity toward the targeted tumors (Sorokina 2009). Interestingly, in 
2008, Rh-123 Br2 received an orphan drug designation from the United States Food and 
Drug Administration for purging tumor cells from bone marrow grafts which would be 
used in bone marrow transplants (Villeneuve 1999, Brasseur et al. 2000, Belostotsky et 
al. 2011). Here, the spin-orbital coupling is enhanced by the electronic perturbation that is 
promoted by the substitution of bromine atoms to the parent compound (Rh-123). This 
leads to an increase in the intersystem crossing rate constant which results in an increase 
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in population of its respective triplet species. To our knowledge, Rhodamine-123 Br2 is 
the only cationic mitochondrial photosensitizer to reach phase III clinical trials for cancer 
therapy. In summary, the mitochondrial accumulation of suitable cationic dyes, 
displaying the above properties, is thought to be responsible for the selective destruction 
of certain tumor cells at the mitochondrial level.       
 With this in mind, the objectives of this study were twofold. First, explore how 
and to which extent the molecular structure of a series of rhodamine dyes affects their 
subcellular localization in a chosen model non-transformed cell line (CV-1). This was 
motivated by the fact that it has been previously hypothesized that selective tumor cell 
kill can be achieved on the basis of the differences in the mitochondrial transmembrane 
potential typically observed between normal and tumor cell lines. Second, because all 
previous studies dealing with mitochondrial targeting have involved tumor and normal 
(non-transformed) cells of different origins (Modica-Napolitano and Aprille 2001, 
Belostotsky et al. 2011), we have attempted to harmonize the cell model used in these 
studies, in order to explore whether by inducing an increase in the mitochondrial 
transmembrane potential, CV-1 cells (normal vs. increased mitochondrial transmembrane 
varieties, respectively) could be used as an appropriate model to investigate the effects of 
mitochondrial targeting on selective cell kill. Here, our motivation has its origins in 
previous studies described by Rossignol and colleagues on the effects of energy substrate 
availability (glucose vs. glutamine) which aimed to study the response of the limitation of 
glucose in various tumor cells. These authors demonstrated that by limiting glucose and 
promoting oxidative phosphorylation via the anaplerotic glutamine pathway, both a non-
transformed cell line (lung fibroblast, MRC5) and a tumor cell line (HeLa), were able to 
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adapt to these changes at the mitochondrial level (i.e., structurally) (Rossignol et al. 
2004). Therefore, we have explored the spectroscopic properties of various rhodamine 
dye derivatives, determined which of these derivatives is exclusively mitochondrial 
localizing in our chosen non-transformed cell line, and explored whether CV-1 cells 
could potentially be used as a model to investigate the effects on selective cell kill via 
mitochondrial targeting.  
 
Glucose and Glutamine as Energy Substrates    
 Glucose is thought to be the preferred energy substrate needed by most cells. 
Under aerobic conditions, mammalian cells metabolize this energy substrate through a 
series of catabolic reactions in the three stages of cellular respiration (Figure 1.5) in 
order to transduce energy (i.e., to promote ATP synthesis). In the first stage, glucose is 
converted into pyruvate (in the cytoplasm) via glycolysis (Figure 1.6). Subsequently, 
pyruvate is converted to acetyl Co-A which transfers its acetyl group to oxaloacetate to 
generate citric acid. This last reaction represents the major feeding pathway along the 
citric cycle (Figure 1.7). In the third stage, the NADH and FADH2 molecules generated 
by the citric acid cycle are fed into the respiratory chain (electron transport chain) 
(Figure 1.8); it is this stage that is especially significant in the production of ATP for the 
cell and is best explained by the chemiosmotic theory proposed by Peter Mitchell in 1961 
(Mitchell 1979). Here, the exergonic energy that results as a consequence of the flow of 
electrons through the respiratory chain is coupled to the simultaneous pumping of protons 
across the inner mitochondrial membrane (i.e., from the matrix to the intermembrane 
compartment). Accordingly, there are  two  major  consequences  that  occur  due  to  this  
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Figure 1.5 The three stages of cellular respiration (Nelson and Cox 2008).  
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Figure 1.6 The glycolytic pathway (Nelson and Cox 2008).  
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Figure 1.7 The citric acid cycle (Nelson and Cox 2008). 
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Figure 1.8 The electron transport chain (Nelson and Cox 2008). 
 
 
 
movement of protons: (i) a pH (i.e., proton) gradient is generated across the inner 
mitochondrial membrane where the proton concentration is lower in the matrix compared 
to  the  cytoplasm  and  (ii) a voltage gradient (mitochondrial transmembrane potential) is 
generated across the inner mitochondrial membrane where it is negative on the inside due 
to the efflux of protons from the matrix side to the intermembrane mitochondrial space. 
Together these two forces result in a net free energy (proton-motive force) (Figure 1.9).  
Because the membrane is impermeable to protons, the protons that re-enter  the  matrix  
must  pass  through  a  proton  channel  lined  with  enzymes,  the ATP synthase (F0F1) 
complex. Consequently, ATP is made using the proton-motive force as a source of 
energy.  Through these unique reactions, mammalian cells can acquire the majority of the 
energy that is required for cellular growth and survival from the metabolism of the main 
energy substrate, glucose.  However, when the availability of glucose is low, glutamine 
can act as a relevant substrate. 
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Figure 1.9 The proton-motive force.  Shown here, the inner mitochondrial membrane separates two 
compartments of different [H
+
], resulting in differences in chemical concentration (ΔpH) and charge 
distribution (Δψ) across the membrane. The net effect is the proton-motive force (ΔG). Here,  R represents 
the thermodynamic constant for ideal gases, T the absolute temperature, C2 /C1 the concentration ratio of 
ions on their respective side of the membrane, Z  the absolute value of its electrical charge (1 for a proton), 
and F the Faraday constant (Nelson and Cox 2008).  
 
 
Glutamine is a versatile amino acid that plays fundamental roles in the 
maintenance and vitality of all cells. It is the most abundant amino acid in the body, 
where 60% of all unbound amino acids are glutamine, the main storage being located in 
the musculature (Nelson and Cox 2008). Commonly, it is used in the building of muscle 
tissue, maintenance of optimal immune function, and is needed for the repair and 
maintenance of intestinal tissue (Young and Ajami 2001). In addition to these regular 
maintenance roles, glutamine can also be employed as a particularly convenient 
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alternative energy substrate when the supply of glucose is limited, which can be the case 
with many fast growing tumors.  For example, Rossignol and collegues demonstrated that 
HeLa cells can achieve 98% of their ATP predominantly by the oxidation of glutamine 
alone (Rossignol et al. 2004).  Interestingly, these authors also observed that while doing 
so HeLa cells, as well as osteosarcoma cells, adapted their mitochondrial network 
structurally and functionally in order to derive energy from glutamine. Intuitively,  the  
utilization  of  glutamine as an energy  substrate  may  correlate  between these observed 
structural changes because the anaplerotic metabolism of glutamine  (Figure 1.10)  takes  
place  in  the  mitochondria  where  the  enzymes needed for its metabolism   
(glutaminase   and   glutamate  dehydrogenase)  are  located (Kovacevic and McGivan 
1983, Matsuno et al. 1987). In this organelle, glutamine is first converted to glutamate by 
the amidohydrolase enzyme, glutaminase. Next, glutamate is converted into α-
ketoglutarate by glutamate dehydrogenase and  subsequently  entered   into   the   citric  
acid cycle (Figure 1.7) and ultimately the electron transport chain (Figure 1.8) thus 
providing  the  cell  with  an  alternative  energy  source.  Therefore, due to  the  increased 
needs of energy for growth and survival, certain tumor cell lines have been observed to 
obtain significant energy by metabolizing additional energy substrates, such as glutamine, 
when the availability of glucose is limited.  
Researchers have also observed that certain tumor cells cannot survive in the 
absence of glutamine and therefore, exhibit a “glutamine addiction” (Wise et al. 2008). 
Classical studies conducted by Eagle in determining the optimal media formulary for 
certain mammalian cell lines, revealed that glutamine was generally needed in 
concentrations much  higher  than  other  amino acids  (Eagle 1955).  Interestingly,  Eagle  
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Figure 1.10 The catabolism of glutamine to the citric acid cycle intermediate, α-ketoglutarate (Eigenbrodt 
and Mazurek 2011).  
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also observed that glutamine plays an essential metabolic role in certain tumor cells 
(HeLa) that glutamic acid could not satisfy, where up to 20 times as much glutamic acid 
compared to glutamine was required to obtain comparative growth. More recently, even 
in the presence of ample glucose, pancreatic cancer cells deprived of glutamine displayed 
no cellular proliferation (Kaadige et al. 2009).  Therefore, glutamine has proven to be not 
only be an alternative energy substrate for fast growing cells, but essential even in high 
glucose media. 
The objective of the last part of our study was to explore the effects of energy 
substrate availability in our chosen non-transformed cell model (CV-1). This was done in 
order to explore whether or not an enhanced mitochondrial transmembrane potential 
could be induced by the stimulation of the anaplerotic pathway of glutaminolysis. 
Ultimately, this pilot study will provide useful information for the future development of 
a single, same cell model in which the effects of mitochondrial targeting on selective cell 
kill could be explored. In order to satisfy this objective, the main energy substrate glucose 
was removed from the cell culture media and replaced with an ample supply of 
glutamine. Ideally, this would suppress the metabolic process of glycolysis and force the 
cells to achieve the majority of their energy primarily from the catabolism of glutamine. 
In theory, this method would increase the contribution of oxidative phosphorylation, in 
cell energy transduction (compared to glycolysis) while potentially inducing an increase 
in the mitochondrial transmembrane potential. Ideally, such increase in inner 
mitochondrial potential would permit the use of a single cell line (here the CV-1 cell line) 
in studies dealing with the question of how and to which extent molecular structure may 
affect the specificity with which more cationic species accumulate in the mitochondria of  
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tumor cells. 
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2. Material and Methods 
2.1 Materials  
 
2.1.1 Chemical Reagents, Biologicals, and Disposables  
 
Rhodamine-110 (Rh-110), Rhodamine-123 (Rh-123), Rhodamine B (RhB) and 
Rhodamine 6g (Rh6g) were obtained from Acros Organics (Morris Plains, NJ).  Ethyl 
alcohol, methyl alcohol, sodium hydroxide, hydrochloric acid, acetone, filter paper (#2 
qualitative), sulfuric acid, ammonium chloride, 3Å molecular sieves, ethyl acetate, silica 
gel TLC plates, neutral aluminum oxide TLC plates, dichloromethane, Penicillin-
Streptomycin (10,000 I.U./ml Penicillin and 10,000ug/ml Streptomycin), fetal bovine 
serum (FBS), dialyzed fetal bovine serum, Trypan Blue biological stain, glutamine, 
glucose, 0.25% trypsin-0.03% EDTA, and 0.25% trypsin-0.03% EDTA in saline (without 
glucose), ethyl alcohol, hydrochloric acid, and sodium hydroxide were purchased from 
Fisher Scientific (Pittsburgh, PA). Sodium bicarbonate, neutral aluminum oxide 
Dulbecco’s Phosphate Buffered Saline without calcium and magnesium (DPBS), 
Dulbecco’s Phosphate Buffered Saline with calcium and magnesium were obtained from 
Sigma-Aldrich Chemical Co. (St. Louis, MO). Anhydrous ethanol for spectroscopic 
experiments was acquired from Electron Microscopy Sciences (Hatfield, PA). 
Rhodamine n-octyl ester (Rh-Oct) was previously synthesized in our laboratory via 
Fisher esterification of Rh-110, using n-octyl alcohol and anhydrous hydrochloric acid 
(Belostotsky et al. 2011). In addition, Rhodamine-123 Br2 (Rh-123Br2) and Rhodamine 
n-octyl ester Br2 (Rh-OctBr2) were also previously synthesized in our laboratory via 
electrophilic aromatic halogenation of the parent dyes: Rh-123 and Rh-Oct (Sorokina 
2009). African green monkey kidney (CV-1) cells (ATCC, CCL-70) and Amphotericin B 
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(25µg/mL) were obtained from the American Type Culture Collection (Manassas, VA). 
All Dulbecco’s Minimum Essential Media (DMEM) used in this study: high glucose with 
glutamine (#11965), high glutamine without glucose (#11966), and high glucose without 
glutamine (#11960) were obtained from Invitrogen (Carlsbad, CA). Carbon dioxide gas 
was purchased from Praxair (Danbury, CT). MitoTracker Deep Red 633 was obtained 
from Molecular Probes (Eugene, OR).  Water was distilled, deionized, and filtered before 
use (Millipore Milli-Q system; resistivity, 18 MΩcm-1). All chemicals were high purity 
grade, and, unless otherwise stated, used as received. Disposables such as: 33mm neck 
bottle filters (0.22μm), sterile centrifuge tubes, 35mm diameter culture dishes containing 
glass coverslip bottoms, serological pipettes, 75cm
2 
culture flasks, pipette tips, and gloves 
were all obtained from Fisher Scientific (Pittsburgh, PA).  
 
2.1.2 Instruments 
Spectroscopic measurements were carried out on a Shimadzu UV-2101 PC 
spectrophotometer (Kyoto, Japan). The fluorescence emission and quantum yield 
experiments were performed using a Timemaster Strobemaster fluorometer from Photon 
Technology International, Inc. (South Brunswick, NJ) which has been factory-calibrated 
to provide corrected emission spectra. Acquired spectra were plotted and analyzed using 
a graphing software package (Igor Pro 6) from Wave Metrics Inc.  (Portland, OR). 
Analysis and characterization of synthesized dyes was performed by High Performance 
Liquid Chromatography (HPLC), mass spectrometry, and 
1
H NMR. HPLC analyses were 
performed on a HP1100 system from Agilent Technology (Palo Alto, CA) equipped with 
an auto-injector, auto-collector, and diode array detector. Mass spectrometry data was 
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acquired using a VG AutoSpec mass spectrometer (UK, Manchester). NMR spectra were 
acquired on a 300MHz spectrometer model Spectrospin DPX300 from Bruker (Billerica, 
MA). Microscopy experiments were carried out on an inverted microscope model Eclipse 
TE2000-U from Nikon equipped with an epi-florescence module model TE 2000T-Fl 
(Nikon) and a back-illuminated CCD camera model Cascade 512B from Photometrics 
(Tucson, AZ). Image acquisition and analysis were carried out using a software package 
(MetaMorph) from Universal Imaging Corp. (Downingtown, PA). In addition, 
microscopy objectives, model Plan Fluor (10x, NA =0.3) and an oil immersion objective 
model Plan Apo (60x, NA = 1.4), as well as the appropriate sets of long-pass dichroic and 
band-pass filters: 528 + 19 nm region (490 + 10 nm excitation) and 685 + 20 nm region 
(635 + 10 nm excitation) (Chroma, Rockingham, VT) were used to aid in microscopy 
experiments. 
 
2.2 Methods  
2.2.1 Buffer Preparation 
  
Powdered DPBS was taken from refrigeration and allowed to warm to room 
temperature. Next, the complete buffer was prepared according to the manufactures 
specification using autoclaved, ultra pure Milli-Q water, a 3L Erlenmeyer flask, a large 
octagonal stir bar, and a magnetic stir plate and subsequently allowed to mix at room 
temperature until all the solid was dissolved. Next, a pH electrode was inserted and used 
to monitor the pH while adjusting it to 7.2 + 0.2 with a few micro liters of 1M HCl or 1M 
NaOH. After adjusting the pH, the completed buffer was filtered using a 33mm bottle-top 
filter (0.22μM) into sterile 500mL glass bottles. In addition, the DPBS with calcium and  
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magnesium was prepared in the same manner as stated above.  
 
2.2.2 Media Preparation  
Dulbecco's Modified Eagle Media (DMEM) was supplemented with precise 
quantities of glucose and glutamine in order to form 4 different DMEM media. Next, 
media #1 (4500 mg/L glucose and 584 mg/L glutamine), media #2 (0 mg/L glucose and 
4234 mg/L glutamine), media #3 (4500 mg/L of glucose and 4234 mg/L glutamine), and 
media #4 (4500 mg/L of glucose and 0 mg/L glutamine) were supplemented with 10% 
FBS, 2% Penicillin-Streptomycin solution, and 0.2% Amphotericin B. In the case of 
media #2, dialyzed FBS was used to avoid the addition of serum sugar. Subsequently, a 
pH electrode was inserted and used to monitor the pH while adjusting each of the DMEM 
media solutions to 7.2 + 0.2 with a few micro liters of 1M HCl or 1M NaOH if needed. In 
addition, all the media solutions contained the pH indicator phenol red which was used to 
visually verify physiological pH during all experiments. Furthermore, the formulary for 
each prepared media can be seen in Table 2.1.  Lastly, all media solutions were filtered 
into sterile 500mL glass bottles using a 33mm bottle-top filter (0.22μM) prior to use. 
 
 
 
 
 
 
 
27 
 
 
 
Components Media #1 Media #2 Media #3 Media #4 
Amino Acids     
Glycine 30 mg/L 30 mg/L 30 mg/L 30 mg/L 
L-Arginine hydrochloride  84 mg/L 84 mg/L 84 mg/L 84 mg/L 
L-Cysteine
.
2HCl 63 mg/L 63 mg/L 63 mg/L 63 mg/L 
L-Glutamine 584 mg/L 4234 mg/L 4234 mg/L 0 mg/L 
L-Histidine hydrochloride
.
H2O 42 mg/L 42 mg/L 42 mg/L 42 mg/L 
L-Isoleucine 105 mg/L 105 mg/L 105 mg/L 105 mg/L 
L-Leucine 105 mg/L 105 mg/L 105 mg/L 105 mg/L 
L-Lysine hydrochloride  146 mg/L 146 mg/L 146 mg/L 146 mg/L 
L-Methionine 30 mg/L 30 mg/L 30 mg/L 30 mg/L 
L-Phenylalanine 66 mg/L 66 mg/L 66 mg/L 66 mg/L 
L-Serine 42 mg/L 42 mg/L 42 mg/L 42 mg/L 
L-Threonine 95 mg/L 95 mg/L 95 mg/L 95 mg/L 
L-Tryptophan 16 mg/L 16 mg/L 16 mg/L 16 mg/L 
L-Tyrosine disodium salt dihydrate (2Na
.
2H20) 104 mg/L 104 mg/L 104 mg/L 104 mg/L 
L-Valine 94 mg/L 94 mg/L 94 mg/L 94 mg/L 
Vitamins         
Choline chloride 4 mg/L 4 mg/L 4 mg/L 4 mg/L 
D-Calcium pantothenate 4 mg/L 4 mg/L 4 mg/L 4 mg/L 
Folic Acid 4 mg/L 4 mg/L 4 mg/L 4 mg/L 
Niacinamide 4 mg/L 4 mg/L 4 mg/L 4 mg/L 
Pyridoxine hydrochloride 4 mg/L 4 mg/L 4 mg/L 4 mg/L 
Riboflavin 0.4 mg/L 0.4 mg/L 0.4 mg/L 0.4 mg/L 
Thiamine hydrochloride 4 mg/L 4 mg/L 4 mg/L 4 mg/L 
i-Inositol 7.2 mg/L 7.2 mg/L 7.2 mg/L 7.2 mg/L 
Inorganic Salts         
Calcium Chloride (CaCl2) (anhyd.) 200 mg/L 200 mg/L 200 mg/L 200 mg/L 
Ferric Nitrate (Fe(NO3)3"9H2O)  0.1 mg/L 0.1 mg/L 0.1 mg/L 0.1 mg/L 
Magnesium Sulfate (MgSO4) (anhydrous) 97.67 mg/L 97.67 mg/L 97.67 mg/L 97.67 mg/L 
Potassium Chloride (KCl) 400 mg/L 400 mg/L 400 mg/L 400 mg/L 
Sodium Bicarbonate (NaHCO3) 3700 mg/L 3700 mg/L 3700 mg/L 3700 mg/L 
Sodium Chloride (NaCl) 6400 mg/L 6400 mg/L 6400 mg/L 6400 mg/L 
Sodium Phosphate monobasic (NaH2PO4
.
H2O) 125 mg/L 125 mg/L 125 mg/L 125 mg/L 
Other Components         
Phenol Red 15 mg/L 15 mg/L 15 mg/L 15 mg/L 
D-Glucose (Dextrose) 4500 mg/L 0 mg/L 4500 mg/L 4500 mg/L 
 
 
Table 2.1 Formulary of all media used: media #1 (optimal glucose/optimal glutamine), media #2 (no 
glucose/ high glutamine), media #3 (optimal glucose/high glutamine), and media #4 (optimal glucose/no 
glutamine). 
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2.2.3 Synthesis of Rhodamine 6g Free Acid 
The Rh6g free acid derivative was synthesized by the saponification of its 
respective parent dye (Figure 2.1). The reaction was carried out by dissolving 0.475g of 
Rh6g in 100mL of distilled, deionized, and filtered water (18MΩcm-1). Approximately 
20mL of ethanol was added to the mixture until all of the Rh6g was dissolved. An initial 
standard 1mL aliquot of the mixture was taken for HPLC analysis. Next, 1mL of 1M 
sodium hydroxide was added to the reaction mixture and continuously stirred under heat 
with the assistance of an octagonal stirring bar, and a magnetic stirring plate for 24 hours. 
The progress of the reaction was monitored by HPLC (reverse phase C18 column; mobile 
phase: 75% methanol and 25% 100mM aqueous NH4Cl) (see Results and Discussion). 
After the HPLC data indicated that the reaction was brought to completion (100% yield), 
the reaction was neutralized with hydrochloric acid. Next, any excess ethanol and water 
were removed by roto-evaporation. Afterwards, the dried product was dissolved in 
acetone and cooled to 5
o
C for 24 hours. After 24 hours, any salt in the mixture was 
removed by cold filtration and the remaining elutant was subjected to roto-evaporation to 
remove all acetone.  Lastly, the solid sample was dried under vacuum at 40
o
C overnight. 
The identity of the newly synthesized Rh6g derivative was confirmed by mass 
spectrometry and 
1
H NMR (see Results and Discussion). 
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Figure 2.1 The saponification of Rhodamine 6g resulting in Rhodamine 6g free acid. 
 
 
2.2.4 Synthesis of Rhodamine B Ethyl Ester 
The RhB derivative was synthesized via Fischer esterification of the parent dye 
using ethyl alcohol (Figure 2.2). The reaction was carried out by dissolving 0.712g of 
RhB in 75mL of anhydrous ethanol (acquired by the use of heat activated 3Å molecular 
sieves). An initial standard 1 mL aliquot was taken for HPLC analysis (reverse phase C18 
column; mobile phase: 75% methanol and 25% 100mM aqueous NH4Cl). Next, the 
mixture was exposed to anhydrous gaseous HCl (50 mmol) which was generated slowly 
by the addition of hydrochloric acid (36%) to concentrated sulfuric acid.  After the HPLC 
data indicated that the reaction was brought to completion (92% yield), ethyl acetate was 
added in excess to decrease possible hydrolysis of the newly synthesized product. 
Subsequently, the reaction mixture was neutralized by the addition of sodium bicarbonate 
until no more CO2 bubbles were seen (approximately 20g). The remaining mixture was 
cooled to 5
o
C and any excess sodium bicarbonate, as well as the sodium chloride 
byproduct, was removed by cold filtration. After filtration, the excess ethanol and ethyl 
acetate were removed by roto-evaporation. Lastly, the solid sample was dried under 
vacuum at 40
o
C overnight. 
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Figure 2.2 Fisher esterification of Rhodamine B resulting in Rhodamine B ethyl ester. 
 
 
2.2.5 Purification of Rhodamine B Ethyl Ester 
The desired product and starting material were separated using wet column 
chromatography. Analysis of silica gel and neutral alumina TLC plates were done to find 
optimal conditions for a separation mixture. To this end, neutral aluminum oxide (80–200 
mesh) was made into a dichloromethane slurry and packed into a column under 
atmospheric pressure. The final crude product was dissolved in dichloromethane and 
loaded onto the column and the dye of interest removed by a 19:1 (v/v) mixture of 
dichloromethane: methanol mobile phase. A total of 18 fractions were collected and 
analyzed by HPLC (reverse phase C18 column; mobile phase: 90% methanol and 10% 
100mM aqueous NH4Cl). Pure fractions 2-4 were combined and dried by roto-
evaporation and analyzed using the same HPLC condition as described above to confirm 
purity (see Results and Discussion). Lastly, the solid sample was dried under vacuum at 
40
o
C overnight.  The identity of the newly synthesized RhB derivative was confirmed by 
mass spectrometry and 
1
H NMR (see Results and Discussion).  
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2.2.6 Spectroscopic Experiments 
Fresh stock solutions of Rh-123, Rh-110, Rh-Oct, Rh6g, RhB, Rh-123Br2, and 
Rh-OctBr2, as well as the newly synthesized free acid and ethyl ester derivatives of Rh6g 
and RhB, respectively (Rh6gFA and RhBEE), were prepared in anhydrous ethanol. The 
absorption spectrum of each dye was investigated in the 200-700nm range using an UV-
visible spectrophotometer, and with a spectroscopic resolution of 1nm. Next, the newly 
acquired spectra were plotted via Igor graphing software and subsequently examined to 
find the maximum wavelength of each at their respective peak absorbance.  
Similarly, 10mL of each dye solution was prepared by diluting the respective 
stock solutions with anhydrous ethanol so that each new solution had similar absorbances 
at the chosen excitation wavelength for fluorescence experiments. Furthermore, this 
dilution process was done in triplicates, using calibrated glassware, and making sure that 
the absorbance of each solution was kept below 0.05 at each dye’s respective peak 
absorbance (investigated prior) in order to avoid inner-filter effects (Demas et al. 1971). 
Corrected fluorescence spectra were recorded using a Timemaster Strobemaster 
fluorometer. Lastly, the acquired fluorescence spectra were plotted via Igor graphing 
software. In addition, the fluorescence quantum yields were calculated (Figure 2.3) using 
Rh-123 (dissolved in ethyl alcohol) as the fluorescence standard ( Rh-123 =0.86) (Pal et al. 
1996).   
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X= R(AR/AX)(BX/BR)(IR/IX)(nX/nR)
2 
 
 
Figure 2.3 Equation used to calculate the fluorescence quantum yields (Demas et al. 1971, Indig et al. 
1996). Here,   is the quantum yield,  A is the absorbance of the solution at the excitation wavelength, B is 
the integrated area under the corrected emission spectrum, I is the relative intensity of the light at the 
excitation wavelength, and n is the refractive index of the solvent. The subscripts x and r refer to the 
unknown and reference solutions, respectively. 
 
 
2.2.7 Rhodamine Dye and MitoTracker Deep Red 633 Preparation for Cell Culture 
Experiments 
Fresh stock solutions of Rh-123, Rh-110, Rh-Oct, Rh6g, RhB, Rh-123Br2, Rh-
OctBr2, as well as the newly synthesized free acid and ethyl ester derivatives, Rh6gFA 
and RhBEE, were prepared in anhydrous ethanol. The concentration of each of the stock 
solutions was determined using a UV-visible spectrophotometer (spectroscopic resolution 
of 1nm), the Beer-Lambert law (Figure 2.4), and each dye’s respective molar extinction 
coefficient (Table 2.2) (Sorokina 2009); the molar extinction coefficients for RhBEE and 
Rh6gFA are the same as their respective parent dyes (Pal et al. 1996). Solutions of the 
rhodamine dyes used in the microscopy experiments were prepared in ethanol by diluting 
the stock solutions in a way that the final dye concentration in the cell culture media used 
for incubation would be 1µM and the final ethanol content at the 0.5% level. Lastly, a 
1µM MitoTracker Deep Red 633 solution was freshly prepared in DMSO according to 
the manufacture’s specification. Furthermore, the final DMSO content of the above 
solution was always maintained at the 0.02% level. 
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A= Ɛ.b.c 
 
Figure 2.4 The Beer-Lambert law used to calculate the concentration of the rhodamine dyes used in CV-1 
cells for imaging. Here, Ɛ is the molar absorbtivity with units of L mol-1cm-1, b is the path length in cm of 
the sample (specifically the path length of the cuvette in which the sample is contained), and c is the 
concentration of the compound in solution, expressed in mol L
-1
. 
 
 
 
 
 
Dye Ɛ λmax(EtOH) (x 10
3
) 
 
 
 
Rh-123
+ 
8.52 
RhB 10.6 
Rh6g
+ 
11.6 
Rh-Oct
+ 
8.52 
Rh-123Br2
+ 
7.25 
Rh-OctBr2
+ 
7.41 
 
 
 
Table 2.2 Molar extinction coefficients (L mol
-1
cm
-1
) of rhodamine dyes in ethanol (Sorokina 2009). 
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2.2.8 The Biological Model 
One million previously frozen CV-1 cells were taken from cryogenic storage and 
thawed in a 37
o
C 50% ethyl alcohol and 50% water bath. Immediately after the cells were 
thawed, the cell culture was started by transferring the cells into a sterile 75cm
2
 canted 
neck cell culture flask with the use of a 1mL sterile serological pipette. Next, 15mL of 
media #1 was added to the flask. The flask was then sealed and placed in an incubator at 
37
o
C, 5% CO2, and 86% humidity. After 24 hours, the culture flask was checked by 
microscopy in order to determine if the cells had adhered to the bottom. After 
determining that the cells had successfully attached, the old media was removed from the 
culture flask and replaced with 15mL of fresh media using sterile technique in order to 
remove any unattached, dead cells. The culture flasks were then monitored daily for 
growth. Typically, the old culture media was replaced with 15mL of fresh media solution 
every 2-3 days. In addition, the cells were allowed to grow until nearly 80% confluent (as 
evaluated by visual inspection). Subsequently, viability was verified by Trypan Blue 
staining and the cells were subcultured at a 1:3 subcultivation ratio twice before any 
experiments were preformed.  
 
2.2.9 Cell Culture Maintenance and Sample Preparation 
The cell culture media was replaced with fresh media solution every 2-3 days 
while the cells were growing in the incubator. Prior to changing the culture media or 
preparation of any samples for experimentation, the laminar flow hood was sterilized 
with a 70% ethyl alcohol solution followed by 30 minutes of exposure to UV light. The 
fresh media solution of choice was warmed in a 37
o
C 50% ethyl alcohol and 50% water 
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bath while the UV light was sterilizing the hood. The old culture media was removed via 
a sterile serological pipette and replaced with 15mL of fresh, pre-warmed media solution 
with the aid of an additional sterile serological pipette.  
The cell culture population was divided once the cells had become nearly 80% 
confluent (as evaluated by visual inspection), characteristically every 3 to 4 days. This 
process was initiated by removing the old culture media with a sterile serological pipette 
as previously described above. The pre-confluent monolayer was washed twice with 10-
15mL of DPBS and discarded in order to remove any residual FBS. To detach the cells, 
3mL of trypsin-EDTA solution was added to each 75cm
2
 culture flask. After the enzyme 
solution was added, the culture flask was recapped and allowed to sit under the hood for 
5 minutes. Next, the flask was removed from the hood and immediately viewed by 
microscopy in order to determine if the cells were small and sphere-like, indicating 
efficient trypsin activity.  In addition, the cells ability to dissociate from the pre-confluent 
monolayer was tested by gently tapping the sides of the culture flask. Once confirmation 
that the cells were detaching from the surface was obtained, 10mL of fresh media 
solution was added to the flask via a sterile serological pipette in order to inhibit further 
trypsin activity. At this point, the same pipette was used to detach the cells by gently 
agitating the mixture up and down several times in order to break apart any cell clumps 
and consequently wash all cells off from the culture flask surface. Next, the detached cell 
culture population was divided and passed into new 75cm
2 
culture flasks at a 1:3 
subcultivation ratio as recommended by the ATCC.  In addition, a 0.5mL aliquot was 
kept to verify viability of the cell culture using Trypan Blue staining. Lastly, 15mL of 
fresh media solution was added to each new flask and placed in the incubator.       
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In the case of sample preparation, all CV-1 cells were harvested in the exponential 
growth phase in their respective media solution as recommended by the ATCC. The 
plating process was initiated by removing the media solution and detaching the cells as 
previously described above. In addition, the cells were plated at a density of 30,000 cells 
per 3mL of growth media on small petri dishes containing a glass coverslip bottom 
(35mm diameter) and incubated 24 hours prior to examination. 
 
2.2.10 Subcellular Localization Studies 
Before acquiring microscopy images, the cells were incubated simultaneously for 
1 hour in growth media #1 in the presence of the desired rhodamine dye (1μM for Rh-
123, Rh-110, Rh-Oct, Rh-123Br2, and Rh-OctBr2 or 0.5μM for Rh6g, Rh6gFA, RhB, and  
RhBEE) and 1μM of MitoTracker Deep Red 633. After the initial incubation period, the 
cells were washed twice with 1-1.5mL DPBS and the fluorescence images recorded 
immediately in fresh DPBS solution containing calcium and magnesium.   
 
2.2.11 Metabolism Studies 
2.2.11.1 Comparison of Early Changes in Cellular Morphology and Mitochondrial 
Transmembrane Potential in CV-1 Cells Every 4 Hours for 0-48 Hours 
CV-1 cells were harvested in exponential growth phase and detached as 
previously described in section 2.2.9.  After detaching the cells, the cell culture solution 
was split into two separate 15mL centrifuge tubes. The cells in centrifuge tube #1 were 
used as the control. These cells were counted and viability verified by Trypan Blue 
staining and subsequently plated at a density of 30,000 cells per 3mL of media #1. 
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Centrifuge tube #2, containing the second half of the detached cell culture solution, was 
centrifuged at 4000 rpm for 5 minutes. After centrifugation, the media was immediately 
decanted in order to remove any old culture media and the pellet immediately 
resuspended in media #2 and centrifuged a second time under the same conditions as 
described above.  Next, the media was decanted a second time and the pellet resuspended 
in a fresh aliquot of media #2. The newly suspended cells were then counted, their 
viability verified by Trypan Blue staining, and plated at a density of 30,000 cells per 3mL 
of their new media. Lastly, all of the dishes containing the newly plated cells were placed 
in the 37
o
C incubator.   
The dishes were examined every 4 hours for any early changes (for 48 hours) in 
cellular morphology and mitochondrial transmembrane potential when switched from 
media #1 to media #2. Before acquiring microscopy images, the cells were incubated for 
10 minutes in the presence of growth media containing 10μM of Rh-123. After the initial 
incubation period, the cells were washed twice with 1-1.5mL DPBS and the fluorescence 
images recorded immediately in 3mL of fresh DPBS solution containing calcium and 
magnesium.  Microscopy experiments were carried out on an inverted microscope model 
at 15x magnification in quintuplets and in a systematic manner in order to avoid biased 
imaging (Figure 2.5). Image acquisition and analysis were carried out using Metamorph 
software. Also, fluorescence from Rh-123 in glycerol was compared as a standard prior 
to imaging to check for any significant deviation of fluorescence intensity as a result of 
significant fluctuations in the mercury lamp during the experiment. Notably, the 
appropriate set of long-pass dichroic and band-pass filters were  used  to  detect  the  
fluorescence  of  Rh-123  in   the   528 + 19 nm  region  (490 + 10 nm excitation).  Lastly,  
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Figure 2.5 Diagram showing how each plate was imaged in quintuplets. Here, the large bold circle 
represents the perimeter of the plate and the small circles each represents the area studied by microscopy.  
 
 
changes in cellular morphology and mitochondrial transmembrane potential were plotted 
and compared via Igor graphing software. 
 
2.2.11.2 Comparison of Changes in Cellular Morphology and Mitochondrial 
Transmembrane Potential in CV-1 Cells Every 12 Hours for 0-72 Hours 
CV-1 cells were harvested in exponential growth phase, viability verified, media 
type switched, and plated into small petri dishes as previously described in section 
2.2.11.1. The dishes were examined every 12 hours (for 72 hours) for any changes in 
cellular morphology or mitochondrial transmembrane potential when switched from 
media #1 to media #2 in the same manner as described in section 2.2.11.1 
.  
2.2.11.3 Changes in Cellular Morphology in CV-1 Cells Over 36 Days 
CV-1 cells were harvested in exponential growth phase, viability verified, and 
media type switched as previously described in section 2.2.11.1.  In this case, the cells 
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were subcultured into 75cm
2
 culture flasks in their new respective media. The culture 
flask were observed at 3, 9, 12, 15, 20, 31, and 36 days for changes in cellular 
morphology when switched from media #1 to media #2 in the same manner as described 
in section 2.2.11.1. Similarly, the culture flasks were viewed in quintuplets and in a 
systematic manner to avoid biased imaging (Figure 2.6).  In addition, the old media was 
replaced with fresh media solution every 2 days and cell population maintained as 
previously described in section 2.2.9. Furthermore, when the culture flasks were not 
being examined or maintained they were placed in the 37
o
C incubator.    
 
 
 
 
 
Figure 2.6 Diagram showing how each was imaged in quintuplets. Here, the small circles represent the 
area studied by microscopy. 
 
 
 
2.2.11.4 Comparison of Mitochondrial Transmembrane Potential at 12 Days with 
Rh-123 and Rh-110 
The results from the above experiment inspired the design of a subsequent 
experiment in which dye uptake could be compared in CV-1 cells when employing a 
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mitochondrial specific (Rh-123) and a non-mitochondrial specific (Rh-110) dye. In order 
to explore suspected changes in the mitochondrial transmembrane potential after 12 days 
in media #2, the cells were harvested in exponential growth phase, viability verified, and 
plated into small petri dishes as previously described in section 2.2.11.1. Here, the cells 
were examined for changes in rhodamine dye uptake when switched from media #1 to 
media #2 for 12 days by incubating them in the presence of either Rh-123 or Rh-110. In 
this specific experiment, a third media condition (media #3, optimal glucose and high 
glutamine) was also introduced. This was done in order to determine whether or not there 
would still remain an increase in dye uptake in the CV-1 cells cultured in a high 
glutamine media, even in the presence of optimal glucose conditions. Data was acquired 
in the same manner as above; however, in this case, the samples were incubated for 1 
hour in the presence of 1μM Rh-123 or 1μM Rh-110 in order to give the Rh-110 dye 
enough time to be taken up by the cells. 
 
2.2.11.5 Further Exploration of Cellular Morphology  
In order to further explore the changes in cellular morphology related to the 
amount of glutamine in the culture media, CV-1 cells were harvested in exponential 
growth phase, viability verified, and media type switched as previously described in 
section 2.2.11.1. Next, a fourth growth condition was introduced where an aliquot of  
CV-1 cells were switched to media #4 (optimal glucose and no glutamine). These cells 
were subcultured into 75cm
2
 culture flasks in their new media and observed at 1, 3, 6, 9, 
and 12 days for changes in cellular morphology in the same manner as previously 
described in section 2.2.11.3. In addition, the old media was replaced with fresh media 
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solution every 2 days and cellular population maintained as previously described in 
section 2.2.9. Lastly, the ability of the CV-1 cells to revert back to their normal, healthy 
growth pattern after being cultured in media #2 for 20 days was investigated. Here, an 
aliquot of cells grown for 20 days in media #2 (part 2.2.11.3) was switched back to media 
#1 using the same method as described in section 2.2.11.1.  Subsequently, the cell culture 
was observed at 5, 10, and 12 days for changes in cellular morphology after being 
switched to media #1.  
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3. Results and Discussion 
3.1. Synthesis, Purification and Characterization of Selective Rhodamine Dyes  
For our investigation, we have chosen nine dyes from the rhodamine family 
motivated on the basis of their structural properties: Rhodamine-123
 
(Rh-123), 
Rhodamine-110 (Rh-110), Rhodamine n-octyl ester (Rh-Oct), Rhodamine 6g (Rh6g), 
Rhodamine 6g free acid (Rh6gFA), Rhodamine B (RhB), Rhodamine B ethyl ester 
(RhBEE), Rhodamine-123 Br2 (Rh-123 Br2), and Rhodamine n-octyl ester Br2 (Rh-Oct 
Br2) (Figure 3.1). The first part of this study included the synthesis and purification of 
the free acid (Rh6gFA) and ethyl ester (RHBEE) derivatives of Rh6g and RhB, 
respectively. The second part of this study included the spectroscopic and photophysical 
characterization of the above rhodamine dyes on the basis of structural changes. 
Information on specific combinations of long-pass dichroic and band-pass filters, as 
needed for fluorescence microscopy, was provided by this systematic evaluation.   
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Dye R1 R2 R3 R4 R5 R6 R7 R8 R9 
Rh-110 H H H H H H H H H 
Rh-123+ H H H H H H H H CH3 
Rh-Oct+ H H H H H H H H C8H17 
Rh6g+ CH3 H CH3 H H CH3 H CH3 C2H5 
Rh6gFA CH3 H CH3 H H CH3 H CH3 H 
RhB H C2H5 C2H5 H H C2H5 C2H5 H H 
RhBEE+ H C2H5 C2H5 H H C2H5 C2H5 H C2H5 
Rh-123Br2
+ H H H Br Br H H H CH3 
Rh-OctBr2
+ H H H Br Br H H H C8H17 
 
 
Figure 3.1 Chemical structure of the rhodamine dyes investigated in this study. 
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3.1.2 Synthesis of Some Rhodamine Derivatives 
3.1.2.1 Synthesis of Rhodamine 6g Free Acid 
The free acid derivative of Rhodamine 6g (Rh6gFA) was synthesized by the 
saponification of the respective parent dye (Figure 3.2). Here, the loss of the ethyl group 
should be evident when the reactant and products are compared using HPLC analysis. 
Therefore, a standard aliquot of the mixture was taken for analysis before the addition of 
sodium hydroxide and the progress of the reaction was monitored by HPLC using a 
reverse phase C18 column (see Methods). Figure 3.3 shows the normalized HPLC 
comparison of the parent dye to that of the synthesized derivative. Here, the starting 
material elutes from the reverse phase column at 2.8 minutes compared to the newly 
synthesized product which elutes at 2.3 minutes. This phenomenon suggests that the loss 
of the ethyl group was achieved through the saponification reaction resulting in the free 
acid derivative. In addition, mass spectrometry and 
1
H NMR data for the Rh6g derivative 
described here is the following: Rh6gFA: EI+ (m/z) for C26H27N2O3, calculated 415.504, 
observed: 415.350,  416.360 (M+1); 
1
H NMR (300 MHz, CD3OD)  8.11 (1H, d, J = 6.9 
Hz), 7.65 (2H, t, J = 6.9 Hz), 7.24 (1H, d, J = 7.2 Hz), 7.07 (2H, s), 6.89 (2H, s), 4.06 
(1H,m), 3.53 (4H, d, J = 6.9 Hz), 2.15 (6H, s), 1.37 (6H, m). 
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Figure 3.2 The saponification of Rhodamine 6g resulting in Rhodamine 6g free acid. 
 
 
 
 
 
 
 
Figure 3.3 Normalized HPLC comparison for the synthesized Rhodamine 6g free acid derivative compared 
to the parent dye.  
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3.1.2.2 Synthesis of Rhodamine B Ethyl Ester 
The ethyl ester derivative of Rhodamine B (RhBEE) was synthesized by Fisher 
esterification of its respective parent dye (Figure 3.4). Here, reaction progress was also 
tracked on basis of time-dependant HPLC analysis. Hence, a standard aliquot of the 
mixture was taken for analysis before exposure to gaseous HCl. The progress of the 
reaction was monitored by HPLC using a reverse phase C18 column (see Methods).  
Figure 3.5 shows the normalized HPLC comparison of the parent dye to that of the 
collected pure fractions of the synthesized ethyl ester derivative. Here, the starting 
material elutes from the reverse phase column at 1.8 minutes whereas the newly 
synthesized product elutes at 2.4 minutes.  Ultimately, this phenomenon suggests that the 
addition of the ethyl group was achieved through the Fisher esterification reaction 
resulting in the ethyl ester derivative. In addition, mass spectrometry and 
1
H NMR data 
for the RhB derivative described here is the following: RhBEE: EI+ (m/z) for 
C30H35N2O3, calculated 471.621, observed: 472.609 (M+1), 443 (-CH2CH3), 399 (-
COOCH2CH3) ; 
1
H NMR (300 MHz, CD3Cl3)  8.32 (1H, d, J = 7.2 Hz), 7.86 (2H, m), 
7.46 (1H, m), 7.09 (6H, m), 4.04 (2H, m), 3.70 (8H,d, J = 6.8 Hz ), 1.32 (12H, t, J = 6.4 
Hz), 0.99 (3H, t, J = 6.8 Hz).  
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Figure 3.4 Fisher esterification of Rhodamine B resulting in Rhodamine B ethyl ester. 
 
 
 
 
 
 
 
Figure 3.5 Normalized HPLC comparison for the synthesized Rhodamine ethyl ester derivative compared 
to the parent dye.  
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3.1.3 Spectroscopic Experiments 
The absorption and florescence emission spectra of fresh stock solutions of Rh-
110, Rh-123, Rh-Oct, Rh6g, Rh6gFA, RhB, RhBEE, Rh-123Br2, and Rh-OctBr2 were 
acquired in ethyl alcohol. Figures 3.6-3.14 show the normalized absorption (left y-axes) 
and fluorescence emission (right y-axes) spectra of all of the rhodamine dyes used in this 
study. In addition, Table 3.1 shows a summary of the wavelengths of maximum 
absorption and the wavelengths of maximum fluorescence as well as the calculated 
quantum yields for each of the selected rhodamine dyes (Rh-123 was used as the 
fluorescence standard ( Rh-123 =0.86) (Pal et al. 1996)). Here, we have investigated how 
and to which extent molecular structure affects the spectroscopic properties and quantum 
yields of the rhodamine dyes of interest.  
The first of the dyes selected to be compared are very similar in structure except 
for the alkyl substitutions of the carbonyl group of the parent dye.  Figures 3.6-3.8 show 
the absorption and fluorescence emission spectra of Rh-110, Rh-123, and Rh-Oct, 
respectively. Comparatively, the esterification of the carbonyl group of Rh-110 (parent 
dye) via the alkyl substitution of a methyl (Rh-123) or an octyl (Rh-Oct) group leads to 
both a 4 nm red (bathochromic) shift in the wavelength of maximum dye absorption and a 
9 nm red shift  in the wavelength of maximum fluorescence. Analogously, virtually no 
changes in fluorescence quantum yields (Table 3.1) were observed among the above 
dyes upon the methyl ( Rh-123 =0.86) and octyl ( Rh-Oct =0.86) alkyl substitution of the 
parent dye ( Rh-110 =0.95). Overall, the spectroscopic properties and quantum yields of 
these three dyes show very little differences upon the alkyl substitutions of the carbonyl 
group.  
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The second group of dyes (Rh6g and Rh6gFA) is also similar in structure and 
photophysical properties when compared. Figure 3.9 and 3.10 show the absorption and 
fluorescence emission spectra of Rh6g and Rh6gFA, respectively. The product of 
hydrolysis (Rh6gFA) of the parent dye (Rh6g), leads to both a 12 nm blue 
(hypsochromic) shift in the wavelength of maximum dye absorption and a 9 nm blue shift 
in the wavelength of maximum fluorescence due to the removal of an ethyl group. 
Comparatively, the quantum yield (Table 3.1) only increases slightly with the removal of 
the ethyl alkyl group ( Rh6gFA =0.81) from the parent dye ( Rh6g =0.72).  Similarly, the 
spectroscopic properties and quantum yields of these two dyes display very little 
differences with the removal of the ester group. 
The same trend was observed when comparing the third group of dyes displaying 
similar structure, RhB (Figure 3.11) and its ethyl ester derivative (RhBEE) (Figure 
3.12). That is, both a 5 nm red shift of maximum dye absorption and a 17 nm red shift of 
maximum fluorescence can be observed as a consequence of the Fisher esterification 
(RhBEE) of the parent dye (RhB). In addition, the quantum yield (Table 3.1) decreases 
with the ethyl esterification ( RhBEE =0.29) of the parent dye ( RhB =0.50). The 
comparison of the spectroscopic properties and quantum yields of this group of dyes also 
reveals little differences upon the esterification of the carbonyl group. Overall, these 
comparative studies have demonstrated that the esterification of rhodamine free acids 
lead to bathochromic shifts in the respective absorption and fluorescence emission 
spectra, along with a decrease in the respective fluorescence quantum yields.  
All of the rhodamine dyes used in this study display similar spectroscopic profiles 
in ethyl alcohol. That is, each of the spectra acquired from the rhodamine dyes show a 
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similar shoulder at the left (blue side) of the absorption envelope.  In addition, the above 
experimental results are in agreement with previous studies exploring the effects of 
structural changes of the parent dyes.  In all cases, it was observed that there was a small 
decrease in the fluorescence quantum yields as well as a slight red shift in the wavelength 
of maximum dye absorption and the wavelength of maximum fluorescence emission 
upon the alkyl substitution of the carbonyl group. In the same manner, it was observed 
that there was a modest increase in the fluorescence quantum yields as well as a small 
blue shift in the wavelength of maximum dye absorption and the wavelength of 
maximum fluorescence emission upon the removal of the alkyl group from the ester 
linkage. Our experimental results are consistent with the results obtained in the classical 
studies in which the spectroscopic and photophysical properties of the above rhodamine 
dyes have been extensively investigated in relation to structural changes (Vogel and 
Rettig 1985, Arbeloa et al. 1989, Arbeloa et al. 1991). 
In general, rhodamine dyes are well known for displaying high fluorescence 
quantum yields. For the compounds considered here, the wavelengths of maximum dye 
absorption vary from 508-556 nm and the respective wavelengths of maximum 
fluorescence emission vary from 519-575 nm. The alkylation of the amino groups is one 
of the main factors that can decrease the fluorescence quantum yields as well as cause 
small bathochromic shifts in the wavelength of maximum absorption and the wavelength 
of maximum fluorescence emission (Vogel and Rettig 1985). By analogy, our 
experimental results suggest that there is a significant decrease in the quantum yields 
between the different free acid dyes: Rh-110 ( Rh-110 =0.95), Rh6gFA ( Rh6g =0.81), and 
RhB ( RhB =0.50). Observably, the Rh-110 derivatives, Rh-123 and Rh-Oct, have no 
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ethyl alkyl substitutions of their amino groups. However, Rh6g and its derivative 
(Rh6gFA) have two ethyl amino groups and RhB and its derivative (RhBEE) have two 
diethyl amino groups, respectively. The trend observed for these last dyes, upon 
increasing the degree of alkylation of the amino groups, is due to a structural change 
within the respective molecules from a planar to pyramidal structures. That is, to the 
respective “open-closed umbrella-like motions” (Arbeloa et al.1991). Consequently, the 
structural change induced upon alkylation increases the rate constants of internal 
conversion from the first excited singlet state (S1) to the ground state (S0) and thus a 
decrease in the fluorescence quantum yields is observed (Pal et al. 1996, Vogel and 
Rettig 1985). Here, the ethyl substitution of the amino groups is thought to stabilize the 
positive charge on the N atom and subsequently increases the π-electron density of the 
xanthene-amine bond upon increasing the degree of alkylation of the amino groups (i.e. 
Rh6gFA vs. RhB) (Arbeloa et al.1991). The relatively modest changes in the spectral and 
photophysical properties observed in this study can be satisfactorily explained by the 
structural changes that take place as a result of the degree of the alkylation of the amino 
groups of our selected rhodamine dyes.  
In addition, we have also investigated how and to which extent bromine atom 
substitution affects the spectroscopic properties of two selected rhodamines. Bromine 
atom substitution of organic dyes is known to result in increased ISC efficiency resulting 
in an increase in photochemical reactivity as compared to the respective parent 
compounds (Shea et al. 1989, Pal et al. 1996, Lacerda et al. 2005). High ISC efficiency is 
a strong requirement for any dye to be considered as a photosensitizer for PDT 
applications. For this reason, two dibrominated rhodamines were included in this study 
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(Rh-123Br2 and Rh-OctBr2). Figures 3.13- 3.14 show the absorption and fluorescence 
emission spectra of the bromine derivatives of Rh-123 and Rh-Oct, respectively. The 
bromine substitution of Rh-123 leads to both a red shift of 6 nm in the wavelength of 
maximum absorption and a red shift of 11 nm in the wavelength of maximum 
fluorescence. Similarly, the bromine substitution of Rh-Oct leads to both a red shift of 7 
nm in the wavelength of maximum absorption and a red shift of 11 nm in the wavelength 
of maximum fluorescence. There is very little difference in the maximum wavelength of 
absorption or maximum wavelength of fluorescence (Table 3.1) when comparing the 
dibrominated derivatives, Rh-123Br2 and Rh-OctBr2, although continuous shift toward 
the red region of the spectrum in the wavelengths of maximum absorption and 
fluorescence upon increasing the degree of bromine substitution of the parent rhodamine 
dye has been previously reported (about 4-5 nm per bromine atom substitution, Lacerda 
et al. 2005). On the other hand, very pronounced effects were observed in the 
fluorescence quantum yields (Table 3.1) upon the bromine substitution of the parent 
dyes: Rh-123 ( Rh-123 =0.86) and Rh-Oct ( Rh-Oct =0.86) compared to Rh-123Br2 ( Rh-
123Br2 =0.38) and Rh-OctBr2 ( Rh-OctBr2=0.40), respectively. These experimental results 
are consistent with previous observations and can be explained by the classical concept of 
heavy-atom effect on intersystem crossing (ISC) efficiency (Turro 1978). 
The substitution of “heavy” atoms (i.e., atoms with a large atomic number, Z), 
such as bromine, increases the efficiency of intersystem crossing (ISC) to the triplet 
manifold by enhancing the spin-orbit coupling. Upon electronic excitation of these 
brominated dyes, a large fraction of the population of the respective first excited singlet 
state (S1) species cross to their respective triplet (T1) manifolds, via ISC. Consequently, 
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this phenomenon results in the increased triplet (T1) population concomitantly with a 
decrease in the respective fluorescence quantum yields (Lacerda et al. 2005). The results 
obtained in this study are consistent with the heavy-atom theory and explain the decrease 
in fluorescence quantum yields that are observed upon bromination of the parent dyes. 
Here, the larger the heavy-atom perturbation, the larger the ISC rate constant, and 
subsequently, the larger the triplet population formed upon dye excitation (Turro 1978). 
Bromine atom substitution has become one of the most common strategies for increasing 
the photoreactivity of organic dyes for PDT. Iodine substitution has also been frequently 
used for such a purpose.  
Our choice for rhodamines as model dyes for this study was largely motivated by 
previous work by Chen and colleagues. These authors examined over 200 cell lines and 
found that tumor cells typically uptake larger amounts of Rh-123 and retain this dye for 
longer periods as compared to most normal cell lines (Chen 1989). In addition, studies of 
a vast number of fluorescent, cationic dyes revealed that Rh-123 has relatively low 
phototoxic properties when used in mammalian cells (Chen 1988). These previous studies 
make Rh-123 an idea candidate for use in fluorescence microscopy. Because the 
absorption (Abs λMax) and fluorescence (Fluor λMax) properties of all rhodamine dyes 
studied here are not very different from each other, they can all be conveniently used as 
fluorescent probes employing the same set of optical filters for Rh-123 that are currently  
found  in  most  fluorescence  microscopes  (Sikder et al. 2005).  This fact facilitates the 
work needed to explore the structural determinates of successful mitochondrial 
localization in our model non-transformed cell line (CV-1).   
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Figure 3.6 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine-110 in 
ethanol. 
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Figure 3.7 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine-123 in 
ethanol.  
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Figure 3.8 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine n-
octyl ester in ethanol.  
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Figure 3.9 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine 6g in 
ethanol. 
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Figure 3.10 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine 6g 
free acid in ethanol. 
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Figure 3.11 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine B in 
ethanol.  
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Figure 3.12 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine B 
ethyl ester in ethanol.  
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Figure 3.13 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine-123 
Br2 in ethanol.  
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Figure 3.14 Normalized absorption (left y-axis) and fluorescence (right y-axis) spectra of Rhodamine n-
octyl ester Br2 in ethanol.  
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Dye Abs  λmax (nm) Fluor  λmax (nm) φf 
Rh-110 508 519  0.95 + 0.05 
Rh-123
+ 512  528  0.86 (Std) 
Rh-Oct
+ 512  528  0.86 + 0.01 
Rh6g
+ 530  548  0.72 + 0.06 
Rh6gFA 518  539  0.81 + 0.02 
RhB 551  558  0.50 + 0.04 
RhBEE
+ 556  575 0.29 + 0.01 
Rh-123Br2
+ 518  539  0.38 + 0.01 
Rh-OctBr2
+ 519  539  0.40 + 0.02 
 
 
 
Table 3.1 Summary of spectroscopic properties and quantum yields for rhodamine dyes. 
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3.2 Subcellular Localization of Rhodamine Dyes  
Tumor cell selectivity is a fundamental component in PDT. One proposed way of 
selective tumor cell killing is via mitochondria targeting with appropriate photosensitizers 
(Davis et al. 1985, Oseroff et al. 1986). In order for this targeting strategy to work, the 
mechanism of cellular uptake and subcellular distribution must be primarily controlled by 
the mitochondrial transmembrane potentials with just minor or negligible contributions 
arising from competing mechanisms such as lipophilic partitioning (Belostotsky et al. 
2011). In this study, the rhodamine dyes from part 3.1 (Rh-123, Rh-Oct, Rh-110, Rh6g, 
Rh6gFA, RhB, RhBEE, Rh-123Br2, and Rh-OctBr2) were investigated in order to 
determine how the structure and charge of each affect the degree of specificity with 
which they  localize in energized  cell mitochondria of our non-transformed (CV-1) cells.   
Figure 3.16 shows fluorescence images of CV-1 cells loaded simultaneously with 
MitoTracker Deep Red 633 (a mitochondrial specific fluorescence probe) and a 
rhodamine dye: Rh-123, Rh-Oct, or Rh-110. The merger of the two fluorescence images 
shows a nearly perfect overlap between the MitoTracker and the prototypical 
mitochondrial dye, Rh-123, as well as its octyl ester derivative, Rh-Oct. Therefore, not 
only Rh-123, a known mitochondrial localizing dye (Chen 1988, Chen 1989, Modica-
Napolitano and Aprille 2001), but the more lipophilic Rh-123 derivative, Rh-Oct, also 
localizes in energized cell mitochondria with great specificity, and apparently even in 
larger quantities as compared to Rh-123. Here, it is reasonable to infer that the lipophilic 
character associated with the octyl ester derivative is still low enough to preclude any 
competitive phenomenon of lipophilic partitioning on subcellular localization. In 
addition,   previous  studies  have  shown  that  when  the  mitochondrial  transmembrane  
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Figure 3.16 Fluorescence microscopy images (80x magnification) of CV-1 cells incubated simultaneously 
for 1 hour with 1 µM Rh-123, Rh n-octyl ester, or Rh-110 and 1 µM MitoTracker Deep Red 633. From left 
to right: fluorescence from MitoTracker (red), rhodamine dyes (green), and the merger of the two 
fluorescence images. In the right panels, yellow represents the subcellular regions in which the 
fluorescence from MitoTracker and the rhodamine dye overlap. 
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potential is depolarized, Rh-Oct leaks slowly from the mitochondria whereas its less 
lipophilic derivative, Rh-123, leaks rapidly from the mitochondria and the cell as a whole 
(Belostotsky et al. 2011). Consequently, Rh-123 dim cells, such as CV-1, become 
substantially easier to image (i.e., more fluorescent) with Rh-Oct due presumably to its 
greater lipophilic character.  Therefore, Rh-Oct may find unprecedented application in 
studies focused on mitochondrial events that take place long after initial depolarization of 
the mitochondrial membrane, whereas Rh-123 is better suited for studies focused on the 
early events that take place during or immediately after depolarization.  
On the other hand, Figure 3.16 shows that when the fluorescence images of 
MitoTracker and Rh-110 are merged, the overlay of the two images indicates that the free 
acid derivative does not show mitochondrial localizing specificity. Instead, Rh-110 is 
diffuse and extends throughout the cytoplasm. This phenomenon is due to the loss of the 
ester alkyl substituent; the dye diffuses throughout the cytoplasm because it is primarily a 
zwitterion at physiological pH (pka of its carboxylic group ~ 4.3) (Jeannot et al. 1997, 
Belostotsky et al. 2011). The higher pH of the mitochondrial matrix (pH ~8.0) compared 
to that of the mitochondrial intermembrane space (pH ~7.2) tends to facilitate the 
accumulation of the zwitterionic form of Rh-110 in the mitochondrial matrix, but this 
process takes longer than the observation time used in our experiments (Jeannot et al. 
1997). The concentration of Rh-110’s cationic form in the cytoplasm/mitochondrial 
intermembrane space (pH ~7.2) is very low as it is estimated that at physiological pH, 
only about 1/1000 of Rh-110 molecules are in the protonated (cationic) form (Jeannot et 
al. 1997). In addition, previous experiments have demonstrated that the transmembrane 
transport process itself requires the protonated (cationic) form (Jeannot et al. 1997, Trapp 
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and Horobin 2005, Horobin et al. 2007). Therefore, only small quantities of Rh-110 are 
thought to cross the mitochondrial membrane through the same pathway used by other 
cationic rhodamine dyes when employing 1µM concentrations and 1h exposure times 
(Belostotsky et al. 2011). However, additional studies have shown that when using higher 
concentrations and longer cell exposure times (i.e., 10µM concentrations and 14h 
exposure times), Rh-110 will eventually find its way into the mitochondria (Jeannot et al. 
1997). The cationic requirement of rhodamine dyes for the rapid and effective 
mitochondrial localization is further confirmed by our experimental results. 
Figure 3.17 shows fluorescence images of CV-1 cells loaded simultaneously with 
MitoTracker Deep Red 633 and the known phototoxic dibrominated rhodamine dyes,   
Rh-123Br2 and Rh-OctBr2.  Here, the merger of the two fluorescence images shows a 
nearly perfect overlap between the MitoTracker and the brominated dyes suggesting that 
these analogs of the ideal mitochondrial localizing dye, Rh-123, also localize in energized 
cell mitochondria of CV-1 cells with great specificity. In addition, previous studies have 
demonstrated that these brominated dyes accumulate in larger amounts and display 
desirable levels of phototoxicity towards tumor cells (Pal et al. 1996, Lacerda et al. 2005, 
Belostotsky et al. 2011). Therefore, any phototoxic agent displaying structural features 
and lipophilic character similar to those of the prototypical mitochondrial dye, Rh-123, 
should theoretically be able to localize in energized cell mitochondrial as well as induce 
the photochemical destruction of tumor cells with a high degree of selectivity.  
Similarly, Figure 3.18 shows fluorescence images of CV-1 cells loaded 
simultaneously with MitoTracker Deep Red 633 and either Rh6g, Rh6gFA, RhB, or 
RhBEE. Here, the mergers of the two  fluorescence  images  of  both  Rh6g  and  RhBEE, 
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Figure 3.17 Fluorescence microscopy images (80x magnification) of CV-1 cells incubated simultaneously 
for 1 hour with either 1 µM Rh-123 Br2, or Rh n-octyl ester Br2 and 1 µM MitoTracker Deep Red 633. 
From left to right: fluorescence from MitoTracker (red), rhodamine dyes (green), and the merger of the two 
fluorescence images. In the right panels, yellow represents the subcellular regions in which the 
fluorescence from MitoTracker and the rhodamine dye overlap.  
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Figure 3.18 Fluorescence microscopy images (80x magnification) of CV-1 cells incubated simultaneously 
for 1 hour with either 0.5 µM Rh6g, 0.5 µM Rh6g free acid, 1 µM RhB, or 1 µM RhB ethyl ester and 1µM 
MitoTracker Deep Red 633. From left to right: fluorescence from MitoTracker (red), rhodamine dyes 
(green), and the merger of the two fluorescence images. In the right panels, yellow represents the 
subcellular regions in which the fluorescence from MitoTracker and the rhodamine dye overlap. 
 
 
 
with their respective MitoTracker images, show a nearly perfect overlap suggesting that 
these two dyes are mitochondrial specific, similar to the ideal mitochondrial dye, Rh-123. 
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On the other hand, the mergers of the two fluorescence images of both Rh6gFA and RhB, 
with their respective MitoTracker images, reveal that there is not a perfect overlap. Here, 
the MitoTracker images display punctuated mitochondria whereas the rhodamine dye 
images reveal an even distribution of dye throughout the cytoplasm of the cell suggesting 
that these two free acid derivatives are not exclusively localized in the mitochondria. This 
lack of mitochondrial specificity is analogous to that observed with Rh-110. These dyes 
diffuse throughout the cytoplasm without mitochondrial localization due to the loss of the 
ester alkyl substituent (i.e. because they are zwitterionic at physiological pHs) (pKa of 
RhB’s carboxylic group ~ 3.2, Woislawski 1953, Mchedlov-Petrossyan et al. 1994).  
These results further re-enforce the idea that the transmembrane transport process itself 
requires the protonated (cationic) form of the rhodamine dye (Jeannot et al. 1997, Trapp 
and Horobin 2005, Horobin et al. 2007). Further experiments would be needed to 
determine if these dyes will eventually find their way into the mitochondria when 
employing higher concentrations and longer cell exposure times similar to those 
previously used with Rh-110 (Jeannot et al. 1997). Based on these experimental results, it 
is reasonable to infer that in order for dyes to localize in the mitochondria with absolute 
specificity, the overall mechanism of cellular uptake and subcellular distribution of the 
above rhodamine dyes must be primarily controlled by the mitochondrial transmembrane 
potential and therefore, the rhodamine dye must be cationic, not zwitterionic.  
Our results confirm the structural requirements for mitochondrial specificity in 
our chosen non-transformed cell line (CV-1), previously only described for high 
mitochondrial transmembrane potential tumor cell lines. The results observed in this 
experiment are consistent with the previously described idea that the transmembrane 
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transport process itself requires the cationic form for successful mitochondrial 
localization (i.e., Rh-123, Rh-Oct, Rh6g, RhBEE, Rh-123Br2, and Rh-OctBr2).  In 
addition, our new zwitterionic dyes (Rh6gFA and RhB) and their respective cationic 
derivatives (Rh6g and RhBEE) are more lipophilic compared to Rh-110.  Therefore, it 
can be concluded that the successful mitochondrial localization of our cationic dyes is 
controlled primarily by the mitochondrial transmembrane potentials and not due to the 
phenomenon of lipophilic partitioning. In the subsequent section, we have selected the 
classical mitochondrial dye, Rh-123, as our primary probe for the exploration of whether 
CV-1 cells could potentially be used as a single, same cell model in which the effects of 
the mitochondrial transmembrane potentials on selective cell kill could be explored. 
 
3.3 Investigation of the Effect of Energy Substrate Availability on Cellular 
Morphology and Mitochondrial Transmembrane Potential in CV-1 Cells  
An enhanced mitochondrial transmembrane potential is a common tumor cell 
phenotype. With the use of fluorescence microscopy, this characteristic transmembrane 
potential can be probed by many cationic dyes such as Rhodamine-123 (Rh-123). This 
dye efficiently localizes in the mitochondria and induces little phototoxicity when used in 
cell cultures. Here, we have explored the possibility that the mitochondrial 
transmembrane potential in our chosen non-transformed cell line (CV-1) could be 
enhanced to the levels typically found in tumor cells through the stimulation of specific 
anaplerotic pathways, such as glutaminolysis. Glutamine is a key metabolite required for 
a variety of diverse roles in mammalian cells including: the anabolic growth, biosynthesis 
of non-essential amino acids and protein translation (Wise and Thompson 2010, Young 
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and Ajami 2001). This pilot study was carried out in order to gain information on whether 
or not CV-1 cells could potentially be used as a single cell model in studies investigating 
selective cell kill via mitochondrial targeting in PDT.    
 
3.3.1 Comparison of Early Changes in Cellular Morphology and Mitochondrial 
Transmembrane Potential in CV-1 Cells Every 4 Hours for 0-48 Hours 
Early changes in cellular morphology and mitochondrial transmembrane potential 
were explored in “normal” CV-1 cells when switched from a media containing optimal 
amounts of the energy substrates glucose and glutamine (media #1) to a media containing 
no glucose and a high amount of glutamine (media #2). Figure 3.19 shows the typical 
morphologies observed in the cell culture at 4, 8, and 12 hours after switching from 
media #1 to media #2. Noticeably, all of the cells display similar morphologies which are 
all commonly observed after initially plating CV-1 cells. In addition, all of the cells are 
growing at equal densities and it appears that they are all of similar size variations. Also, 
it is evident that there is no noticeable difference in the cellular morphology trend 
observed between either of the two growth conditions. In addition, the cellular 
morphologies can be clearly seen in the fluorescence images (Figure 3.20) when these 
cells were incubated with the prototypical mitochondrial probe, Rh-123, to test for 
increased dye uptake, indicative of an enhanced mitochondrial transmembrane potential. 
Analogously, Figure 3.21 reveals no noticeable trend in the average integrated 
fluorescence intensity per cell, suggesting that the mitochondrial transmembrane potential  
73 
 
 
 
 
 
 
Figure 3.19 Bright field images (15x magnification) at 4, 8, and 12 hours showing the different 
morphologies of CV-1 cells incubated either  in media #1 (optimal glucose/optimal glutamine; left panel) 
or in media #2 (no glucose/high glutamine; right panels).   
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Figure 3.20 Fluorescence images (15x magnification) at 4, 8, and 12 hours of CV-1 cells incubated either 
in media #1 (optimal glucose/optimal glutamine; left panel) or in media #2 (no glucose/high glutamine; 
right panels).   
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Figure 3.21 Average integrated fluorescence intensity comparison per CV-1 cell incubated either in media 
#1 (optimal glucose/optimal glutamine) or in media #2 (no glucose/high glutamine) every 4 hours for 48 
hours.  
 
 
is nearly the same under both growth conditions. Therefore, it is reasonable to infer that 
there is no difference in trend observed in cellular morphology or mitochondrial 
transmembrane potential in the first 12 hours when CV-1 cells are switched from media 
#1 to media #2. 
Figure 3.22 shows the typical morphologies found in the cell culture at 16, 20, 
and 24 hours after switching from media #1 to media #2. In this figure, it can be seen that 
at  each time interval all of the CV-1 cells are growing at comparable densities  and  there 
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Figure 3.22 Bright field images (15x magnification) at 16, 20, and 24 hours showing the different 
morphologies of CV-1 cells incubated either  in media #1 (optimal glucose/optimal glutamine; left panel) 
or in media #2 (no glucose/high glutamine; right panels).   
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are no obvious differences in the cellular morphology trend observed between the two 
growth conditions at 16 hours. However, it can be seen that at 20 hours the cells 
incubated in media #2 display an increase in the proportion of slightly elongated cells, 
also eminent at 24 hours. Furthermore, this increase in slightly elongated cells can be 
clearly seen in the fluorescence images (Figure 3.23) of the cells incubated in media #2 
at both 20 and 24 hours.  On  the  other  hand,  Figure 3.21  reveals  no detectable 
difference in trend observed between the two growth conditions at 16, 20, or 24 hours    
when the average integrated fluorescence intensity per cell is compared. Therefore, it is 
reasonable to infer that there is no enhancement of the mitochondrial transmembrane 
potential during the first 24 hours when the cells were switched from media #1 to media 
#2.  However, there is a modest trend observed in cellular morphology change beginning 
at 20 hours after switching energy substrates from primarily glucose to primarily 
glutamine.  
The same cell culture incubated in media #1 and media #2 was continually 
observed every 4 hours for an additional 24 hours. Figure 3.24 shows the typical 
morphologies found under both conditions at 28, 32, and 36 hours. Here, there is an 
observable population of slightly elongated cells in the cell cultures comparative to those 
seen at 20 hours (Figure 3.22). There is no noticeable trend in the change in cellular 
morphology other than a small population of slightly elongated cells in media #2 after 
initially switching energy substrates from primarily glucose to primarily glutamine. 
Conversely, it can be observed that there is a small portion of slightly elongated cells 
which begin to appear in the cell culture incubated under control conditions (media #1) at 
28 hours. Again,  this distribution of observed cellular morphologies is  made  even  more  
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Figure 3.23 Fluorescence images (15x magnification) at 16, 20, and 24 hours of CV-1 cells incubated 
either in media #1 (optimal glucose/optimal glutamine; left panel) or in media #2 (no glucose/high 
glutamine; right panels).   
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Figure 3.24 Bright field images (15x magnification) at 28, 32, and 36 hours showing the different 
morphologies of CV-1 cells incubated either  in media #1 (optimal glucose/optimal glutamine; left panel) 
or in media #2 (no glucose/high glutamine; right panels).   
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evident when viewing the fluorescence images (Figure 3.25) of these cells. Furthermore, 
Figure 3.26 shows that the morphologies found in the cells at 40, 44, and 48 hours are 
still displaying the same morphological trend noted at 36 hours (Figure 3.25) under both 
conditions. That is, there is still an increased population of slightly elongated cells 
observed in the cell culture incubated in media #2. Similarly, the observed morphologies 
are more evident when the mitochondrial transmembrane potential is probed employing 
the fluorescent dye, Rh-123 (Figure 3.27). Moreover, the average integrated fluorescence 
intensity per cell was acquired and plotted (Figure 3.21)  with  still  no  observable  
difference in trend within the initial 48 hours after the cells were switched from media #1 
to media #2.           
 The results obtained here suggest that the enhanced mitochondrial transmembrane 
potential that is typically found in tumor cells cannot be induced in CV-1 cells within the 
first 48 hours by supplementing the growth media with copious amounts of glutamine, 
forcing these cells to use the anaplerotic pathway of glutaminolysis which is commonly 
employed by various tumor cell lines. Notably, there was an observable difference in the 
time interval in which the CV-1 cells start to display a slightly elongated morphology. In 
order to explore this effect in more detail, an additional experiment was designed and 
carried out in which the cellular morphology and mitochondrial transmembrane potential 
were monitored and compared for an additional 24 hour period of incubation.  
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Figure 3.25 Fluorescence images (15x magnification) at 28, 32, and 36 hours of CV-1 cells incubated 
either in media #1 (optimal glucose/optimal glutamine; left panel) or in media #2 (no glucose/high 
glutamine; right panels).   
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Figure 3.26 Bright field images (15x magnification) at 40, 44, and 48 hours showing the different 
morphologies of CV-1 cells incubated either  in media #1 (optimal glucose/optimal glutamine; left panel) 
or in media #2 (no glucose/high glutamine; right panels).   
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Figure 3.27 Fluorescence images (15x magnification) at 40, 44, and 48 hours of CV-1 cells incubated 
either in media #1 (optimal glucose/optimal glutamine; left panel) or in media #2 (no glucose/high 
glutamine; right panels).   
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3.3.2 Comparison of Changes in Cellular Morphology and Mitochondrial 
Transmembrane Potential in CV-1 Cells Every 12 Hours for 0-72 Hours 
The study in 3.3.1 was repeated where CV-1 cells were switched from media #1 
to media #2. However, in this study the cells were observed every 12 hours for 72 hours, 
an additional 24 hours than in part 3.3.1. This was done in order to determine if there 
were further changes in cellular morphology or enhancement of the mitochondrial 
transmembrane potential that could be observed in the first 72 hours. The same trend in 
cellular morphology was observed in the first 48 hours as in part 3.3.1. Figure 3.28 
shows  the  typical  morphologies  found  in  the  cell  culture  at  60  and  72  hours  after 
switching from media #1 to media #2. In this figure, it is observed that there is still an 
increase in the population of slightly elongated cells observed in the culture incubated in 
media #2 and a seemingly unequal distribution of this same morphology found in the 
cells grown in media #1.  In addition, this morphology distribution can also be seen in the 
cellular fluorescence images (Figure 3.29). The average integrated intensity was acquired 
from all the fluorescence images of the CV-1 cells incubated with Rh-123 and 
subsequently plotted for comparison. Figure 3.30 shows that there is no clear trend 
observed when comparing the Rh-123 dye uptake of the CV-1 cells in the initial 72 hour 
period.  
The difference in time intervals at which the CV-1 cells exhibit a slight change in 
cellular morpholgy observed in the previous experiment sparked interest in screening for 
any additional changes over a longer time period. Consequently, a study was set up in 
which CV-1 cell cultures could be monitored for any major changes in cellular 
morphology over a 36 day time period when grown in media #1  compared  to  media  #2. 
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Figure 3.28 Bright field images (15x magnification) at 60 and 72 hours showing the different 
morphologies of CV-1 cells incubated either  in media #1 (optimal glucose/optimal glutamine; left panel) 
or in media #2 (no glucose/high glutamine; right panels).   
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Figure 3.29 Fluorescence images (15x magnification) at 60 and 72 hours of CV-1 cells incubated either in 
media #1 (optimal glucose/optimal glutamine; left panel) or in media #2 (no glucose/high glutamine; right 
panels).   
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Figure 3.30 Average fluorescence intensity comparison per CV-1 cells incubated either in either media #1 
(optimal glucose/optimal glutamine) or media #2 (no glucose/high glutamine) every 12 hours for 72 hours.   
 
 
3.3.3 Comparison of Changes in Cellular Morphology in CV-1 Cells Over 36 Days 
The morphology changes observed for long periods of incubation as shown in 
Figures 3.31-3.32 were very pronounced. Figure 3.31 shows the typical morphologies 
found in the above cell culture at 3, 9, and 12 days for the cells grown in media #1 and 
media #2. Comparatively, there appears to be a small population of slightly elongated 
cells in media #2 observed at 9 days. Interestingly, it can be seen that at 12 days there 
appears to be a remarkable difference in morphology between the two growth conditions. 
Here, the cells in media #1 are still growing in a normal, healthy manner typical of CV-1  
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Figure 3.31 Bright field images (15x magnification) showing the different morphologies at 3, 9, and 12 
days for CV-1 cells incubated either  in media #1 (optimal glucose/optimal glutamine; left panel) or in 
media #2 (no glucose/high glutamine; right panels).   
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Figure 3.32 Bright field images (15x magnification) showing the different morphologies at 20, 31, and 36 
days of CV-1 cells incubated either  in media #1 (optimal glucose/optimal glutamine; left panel) or in 
media #2 (no glucose/high glutamine; right panels).   
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cells. On the other hand, the cells in media #2 emerge as visibly more granular and 
significantly larger in size. Additionally, in some cases the nucleus of the cells cultured in 
media #2 seems to be visibly larger. Also, there were no distinct differences in cellular 
morphology observed between the two growth conditions at 12 and 15 days (data not 
shown). Figure 3.32 shows the typical morphologies found in the cell culture at 20, 31, 
and 36 days for the cells grown in media #1 to media #2. In this figure, it can be seen that 
all of the cells grown in media #1 at each time interval appear to be growing normal and 
in a healthy monolayer to near confluence, however, the cells in media #2 at 20 days 
appear to be slightly more round in shape distribution and do not appear to be growing in 
the same confluent pattern. This growth pattern and enlarged morphology can be 
observed at 31 days and persists until 36 days where the cells are significantly larger and 
unhealthy. These alterations in cellular morphology may be possibly attributed to 
autophagy, however, further testing using methods such as an autophagy detection kit 
would be needed in order to be certain (Mizushima et al. 2010). Overall, the results 
observed under  the  growth  conditions  at  12  days, and longer time periods,  suggest  
that  the  over   stimulation  of   the glutaminolysis pathway has a significant long-term 
effect on the growth of these cells. 
Glutamine is a key metabolite needed by mammalian cells. It is known to donate 
its amide group in at least three enzymatic steps for purine synthesis and two steps in 
pyrimidine synthesis as well as contributing to the non-essential amino acid needs of the 
cell (Wise and Thompson 2010, Young and Ajami 2001, Ahluwalia et al. 1990). This 
contribution of glutamine to amino acid biosynthesis ascertains it as an essential factor 
for the protein translation needs of the cell, especially tumor cells because they typically 
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grow faster. Previous studies have shown that a significant amount of the glutamine taken 
up by certain cells is not used for anabolic metabolism (Nicklin et al. 2009). Rather, it 
may have many other important functions in various cellular pathways including the 
activation of protein translation and the inhibition macroautophagy in various cells 
(Wullschleger et al. 2006). Nonetheless, the late changes (i.e., 31+ days) in cellular 
morphology observed in the absence of glucose indicate that the CV-1 cells cannot 
sustain a close to normal growth pattern for long periods without glucose. Further 
experiments will be needed in order to better understand the determinants of the major 
morphological changes associated with long-term use of glutamine as the primary energy 
substrate in growth media.  
 
3.3.4 Exploration of Cellular Morphology and Comparison of Mitochondrial 
Transmembrane Potential at 12 Days with Rh-123 and Rh-110 
The previous experiments revealed that at 12 days there is a significant difference 
in cellular morphology observed between the cells cultured in media #1 compared to 
those in media #2. Although significantly enlarged, the cells in media #2 at this time 
period maintained a growing pattern typical of CV-1 cells.  That is, they stretched and 
grew towards each other and cellular proliferation was observed. The over abundance of 
glutamine in the growth media is therefore thought to be responsible for the observable 
difference in cellular morphology.  Recent studies suggest that glutamine is also the 
primary mitochondrial substrate and is needed for maintaining the mitochondrial 
transmembrane potential in mammalian cells (DeBerardinis et al. 2007). Moreover, some 
tumor cells are known to consume significant amounts of glutamine that exceed the cell’s 
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use of glutamine for protein translation and nucleotide biosynthesis (Wise et al. 2008, 
DeBerardinis et al. 2007). Therefore, it was further hypothesized that the CV-1 cells 
displaying the noticeable change in cellular morphology at 12 days, presumably due to an 
increased glutamine metabolism, may also display an enhanced mitochondrial 
transmembrane potential similar to the one found in many tumor cells.    
The subsequent experiment compared the dye uptake of cationic Rh-123 
(exclusively mitochondrial) and zwitterionic Rh-110 (non-mitochondrial). Here, it is 
important to note that while the mitochondrial localization of Rh-110 under comparable 
experimental conditions is a slow process (Jeannot et al. 1997), the respective cell uptake 
in the cytosol is relatively fast as will be seen in the following figures. Therefore, 
incubation times of 1 hour and concentrations of 1 μM for both dyes were used in order 
to give the Rh-110 dye enough time to be taken up by the cells. Figure 3.33 and Figure 
3.34 show the fluorescence and bright field images of Rh-123 and Rh-110, respectively. 
Both figures show a visual increase in fluorescence intensity for the cells cultured for 12 
days in media #2. In addition, Figure 3.35 and Figure 3.36 show the bar graphs of the 
integrated fluorescence intensity per cell for the cells cultured in media #1 and media #2 
for Rh-123 and Rh-110, respectively. Comparatively, the integrated fluorescence 
intensity per cell for those incubated in Rh-123 is nearly 40 times more for the cells 
cultured in media #2 compared to those cultured in media #1. Also, the integrated 
fluorescence intensity per cell for those incubated in Rh-110 it is nearly 13 times more 
for those cultured in media #2 compared to those cultured in media #1. Collectively, 
these observations suggest that the cells cultured in media #2 are taking up more Rh-123 
and Rh-110 compared to those  cultured  in  media #1.  In  order  to  further  explore  this  
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Figure 3.33 Top panels: visual comparison of fluorescence of CV-1 cells (15x magnification) incubated 
with 1μM Rhodamine-123 for 1 hour.  Left: CV-1 cells previously grown for 12 days in media #1 (optimal 
glucose/optimal glutamine; left panel) and media #2 (no glucose/high glutamine; right panels). Lower 
panels: respective bright field images. 
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Figure 3.34 Top panels: visual comparison of fluorescence of CV-1 cells (15x magnification) incubated 
with 1μM Rhodamine-110 for 1 hour.  Left: CV-1 cells previously grown for 12 days in media #1 (optimal 
glucose/optimal glutamine; left panel) and media #2 (no glucose/high glutamine; right panels).  Lower 
panels: respective bright field images. 
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Figure 3.35 Average integrated fluorescence intensity comparison (1μM Rhodamine-123 for 1 hour) per 
CV-1 cell cultured either in media #1 (optimal glucose/optimal glutamine) and media #2 (no glucose/high 
glutamine) for 12 days.   
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Figure 3.36 Average integrated fluorescence intensity comparison (1μM Rhodamine-110 for 1 hour) per 
CV-1 cell cultured either in media #1 (optimal glucose/optimal glutamine) and media #2 (no glucose/high 
glutamine) for 12 days.   
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phenomenon, the bar graphs displaying the integrated fluorescence intensity per cell were 
corrected for the enlargement in size of the cells cultured in media #2.  Figure 3.37 
shows that the average area per cell for those incubated with Rh-123. Here, the average 
area per cell is 1 + 0.2 units of area for those cells cultured in media #1 and the average 
area per cell is 13 + 1 units of area for those cultured in media #2. Similarly, Figure 3.38 
shows that the average area per cell for those incubated with Rh-110. Here, the average 
area per cell is 1 + .1 units of area for those cells cultured in media #1 and the average 
area per cell is 10 + 0.9 units of area for those cultured in media #2. These average cell 
areas/sites (5 distinct images for each) were obtained using the sampling strategy 
described in section 2.2.11.1 of Materials and Methods. Figure 3.35 and Figure 3.36 
were then corrected for the differences in size described in Figure 3.37 and Figure 3.38. 
After correcting for size, the average fluorescence intensity per cell for those incubated in 
Rh-123 is nearly 3 times more for the cells cultured in media #2 compared to those the 
cells cultured in media #1 (Figure 3.39).  In addition, the average fluorescence intensity 
per cell for those incubated in Rh-110 is only about 1.3 times higher for the cells cultured 
in media #2 compared to those cultured in media  #1  (Figure 3.40). Initially, it was 
hypothesized that the CV-1 cells displaying the observed change in cellular morphology  
at 12 days would also display an enhanced mitochondrial transmembrane potential in 
analogy to what is found in many tumor cells. These experiments indicate that the cells 
cultured in media #2 are taking significantly more Rh-123 as compared to Rh-110 when 
switched from media #1 to media #2. The higher accumulation of Rh-123, as compared to 
Rh-110, suggests the possible enhancement of the mitochondrial transmembrane potential 
observed in the CV-1 cells cultured in media #2. Comparatively, there is not a  significant   
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Figure 3.37 Average area comparison per cell of CV-1 cells previously grown in media #1 (optimal 
glucose/optimal glutamine) or in media #2 (no glucose/ high glutamine) for 12 days incubated in 1μM 
Rhodamine-123 for 1 hour.  
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Figure 3.38 Average area comparison per cell of CV-1 cells previously grown in media #1 (optimal 
glucose/optimal glutamine) or in media #2 (no glucose/ high glutamine) for 12 days incubated in 1μM 
Rhodamine-110 for 1 hour. 
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Figure 3.39 Size corrected fluorescence intensity comparison per cell of CV-1 cells previously grown 
media #1 (optimal glucose/optimal glutamine) or in media #2 (no glucose/ high glutamine) for 12 days 
incubated in 1μM Rhodamine-123 for 1 hour. 
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Figure 3.40 Size corrected fluorescence intensity comparison per cell of CV-1 cells previously grown in 
media #1 (optimal glucose/optimal glutamine) or in media #2 (no glucose/ high glutamine) for 12 days 
incubated in 1μM Rhodamine-110 for 1 hour. 
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difference in the cells cultured in media #2. Comparatively, there is not a significant 
difference in the lipophilicity between the two dyes; Rh-123 has one additional CH3. 
However, at physiological pH, Rh-123 is a cation while Rh-110 is a zwitterion (pKa of its 
carboxylic group ~ 4.3 (Jeannot et al. 1997)). Our subcellular colocalization results as 
well as previous experiments have demonstrated that the rapid transmembrane transport 
process itself requires the protonated (cationic) form (Jeannot et al. 1997, Trapp and 
Horobin 2005, Horobin et al. 2007). An increase in pumping of protons to the 
intermembrane space in media #2 would potentially lead to an enhancement in the 
mitochondrial transmembrane potential and explain the enhanced uptake of Rh-123 
observed in that media. The relatively small enhancement of Rh-110 uptake in media #2, 
as compared to media #1, is also in keeping with the idea that under our experimental 
conditions the transmembrane potential-driven mitochondrial localization of this 
zwitterionic dye is negligible. Therefore, the experimental results observed in these 
experiments suggest that the mitochondrial transmembrane potential may possibly have 
been enhanced by supplementing the growth media with an abundant supply of 
glutamine.   
The above experimental results inspired another experiment in order to explore 
whether or not there would still exist an increase in Rh-123 uptake in the CV-1 cells 
cultured in a high glutamine media while also in the presence of optimal amounts of 
glucose. Here, a third media condition was introduced (media #3, optimal amounts of 
glucose and high amounts of glutamine) in which Rh-123 dye uptake could be compared 
for CV-1 cells cultured in media #1, media #2, and media #3 for 12 days. Figure 3.41 
and Figure 3.42 show the size corrected fluorescence intensity comparison for those cells  
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Figure 3.41 Size corrected fluorescence intensity comparison (1μM Rhodamine-123 for 1 hour) per CV-1 
cell cultured in media #1 (optimal glucose/optimal glutamine), media #2 (no glucose/high glutamine), and 
media #3 (optimal glucose/high glutamine) for 12 days.   
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Figure 3.42 Size corrected fluorescence intensity comparison (1μM Rhodamine-110 for 1 hour) per CV-1 
cell cultured in media #1 (optimal glucose/optimal glutamine), media #2 (no glucose/high glutamine), and 
media #3 (optimal glucose/high glutamine) for 12 days.   
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incubated with Rh-123 or Rh-110, respectively. After correcting for size, the average 
fluorescence intensity per cell for those incubated in Rh-123 was found to be nearly  3.2 
times more for the cells cultured in media #2 compared to those cells cultured in media 
#1 and 1.1 times more for the cells cultured in media #3 compared to those cells cultured 
in media #1 (no statistically significant differences between media #1 and media #3).  
Likewise, in this experiment the average fluorescence intensity per cell for those 
incubated in Rh-110 is nearly 1.4 times more for the cells cultured in media #2 compared 
to those cultured in media #1 and only 1 times more for the cells cultured in media #3 
compared to those cells  culture  in  media  #1 (also a result that does not appear to be 
statistically significant). The observed increase in dye uptake of both Rh-123 and Rh-110, 
for the cells cultured in media #2, confirms the trend observed in previous experiments. 
Interestingly, the cells cultured in a high glutamine media, also containing optimal 
amounts of glucose, did not display any significant increase in dye uptake.  Therefore, it 
is reasonable to infer that the changes in cellular morphology and increase of dye uptake 
observed in media #2 can be satisfactorily attributed to the copious amounts of glutamine 
found in this last media, however, both phenomena (morphology changes and enhanced 
dye uptake) apparently only take place when the supply of glucose is limited.   
 
3.3.5 Further Exploration of Glutamine Effects on the Cellular Morphology in CV-1 
Cells 
The changes in cellular morphology observed in the CV-1 cells cultures upon 
switching the growth media from one of optimal amounts of glucose and glutamine 
(media #1) to one of no glucose and high glutamine (media #2) inspired the design of 
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another two part experiment. The first was the effect on cellular morphology in CV-1 
cells when the growth media was changed from media #1 to a media containing optimal 
amounts of glucose and no glutamine (media #4). The second was the effect on cellular 
morphology as well as the growth and proliferation of the significantly enlarged cells 
(previously grown in media #2 for 20 days) when switched back to optimal media (media 
#1) and subsequently cultured for 12 days. These experiments were carried out in order to 
gain a better understanding on how the amount of glutamine in the growth media can 
influence the growth and morphology of our CV-1 cells.   
Figure 3.43 shows the typical morphologies of CV-1 cells at 1, 3, 6, 9, and 12 
days when switched from media #1 to media #4. After 1 day, the cells were observed to 
be growing in a manner typical of the CV-1 cell line. In addition, no major changes in 
cellular morphology were observed. However, after 3 days the morphology of the cells 
appears to be slightly elongated and the cells are starting to stretch slightly. After 6 days, 
there was a significant amount of cell death observed in the culture. In addition, it seems 
that the cells exhibit an unhealthy, string-like appearance. This observation of increased 
cell death and string-like cellular morphology is present at 9 and 12 days as well.  
Furthermore, there was no major evidence of cellular proliferation observed at 6, 9, or 12 
days. Therefore, the lack of glutamine in the cell culture media also results in a unique 
difference in cellular morphology in the CV-1 cells as well as well as increased cell 
death. 
Keeping this in mind, it is reasonable to infer that glucose and glutamine are 
essential in maintaining a healthy cell culture over long periods of time. Both of these 
nutrients are needed to induce  critical  biosynthetic  pathways  and  cell  cycle  regulators  
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Figure 3.43 Bright field images (15x magnification) showing the different morphologies of CV-1 cells 
after being switched from media #1 (optimal glucose/optimal glutamine) to media #4 (optimal glucose/no 
glutamine) and cultured for 12 days.   
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which are required for cell division (Kaadige et al. 2009). In a series of experiments, 
Kaadige and colleagues demonstrated that both of these nutrients play independent roles 
in the induction of certain pathways and that the combination of both nutrients was found 
to induce multiple pathways which are required for cell division. Specifically, they found 
that cells grown in a media containing high amounts of glucose but lacking glutamine 
displayed low glucose uptake. Therefore, the results observed here further re-enforce the 
need for optimal amounts of both glucose and glutamine in order to maintain a healthy, 
proliferating cell culture.   
Lastly, the effect on cellular morphology when switching the enlarged CV-1 cells, 
previously grown in media #2 for 20 days, back to media #1 (for 12 days) was 
investigated. Figure 3.44 shows the distinctive morphologies that were observed after 
culturing the cells in media #2 for 20 days (“Before Media Change”) as well as the 
morphologies seen at 5, 10, and 12 days  when  switched  back  to  media #1.  Before 
switching the growth media to media #1, they appear to be enlarged as well as very 
granular. After 5 days, in media #1 the cells were observed to be growing in a manner 
that is more common in a healthy CV-1 cell culture; the cells appear to be less granular as 
well as stretching near each other in a means of forming a monolayer. After 10 days, in 
media #1 it appears that there in an increased number of  healthy  cells  in  the  culture  as  
well  as  an  increase in cellular proliferation with only a few of the enlarged cells 
remaining in the culture.  After 12 days, it was observed that the cell culture appears to be 
similar to a normal, healthy CV-1 cell culture. Therefore, this experiment suggests that 
the morphology trend observed in the CV-1 cells cultured in media #2 could be reversed 
when  switching  the  cells  back  to  optimal  media  conditions.  Furthermore,  it  can  be  
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Figure 3.44 Bright field microscopy images showing the different morphology changes of CV-1 cells 
previously incubated in media #2 (no glucose/high glutamine) for 20 days and subsequently switched back 
to media #1 (optimal glucose/optimal glutamine). 
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concluded that the granular cells observed at 12 days in media #2 (part 3.3.3) are not 
senescent because the experimental   results   obtained   here  confirms  that  the  enlarged  
cellular morphology observed at 12 days can be reversed. 
The results observed here further re-enforces that optimal amounts of glucose and 
glutamine are needed for the normal cell growth and proliferation of CV-1 cells in 
culture. It is evident that there is a direct correlation between the addition of glucose to 
the growth media and the reversal of the cellular morphology observed in the cell culture 
previously incubated in media #2 for long time periods (20 days). In addition, this effect 
on cellular morphology does not appear to take place right away. That is, the cells 
previously grown in media #2 for 20 days started to reverted back to a normal growing 
pattern after 3 days when switched back to a media consisting of optimal amounts of 
glucose and glutamine (media #1). Therefore, the effect on cellular morphology observed 
when a lack of the appropriate amounts of glucose and glutamine were provided to the 
CV-1 cells, further supports the hypothesis that both glutamine and glucose are needed in 
combination in order to maintain a normal, healthy growing pattern in CV-1 cells for 
long time periods.  
In summary, we have observed that there is a direct effect of the energy substrate 
availability on cellular morphology, and apparently also mitochondrial transmembrane 
potential in CV-1 cells. Our results indicate that there is a dramatic change in cellular 
morphology as well as an increase on Rh-123 and Rh-110 dye uptake evident at 12 days 
when removing all glucose from the growth media and supplementing it with excess 
glutamine. In addition, this change in cellular morphology can be reversed over time 
when the availability of glucose is restored. Lastly, we have demonstrated that glutamine, 
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in combination with glucose, is also needed by CV-1 cells in order to maintain a healthy 
growing pattern over long time periods. Overall, this pilot study has provided us with 
information on whether or not CV-1 cells could potentially be used as a single-cell model 
in which the effects of the mitochondrial transmembrane potentials on selective cell kill 
could be explored. Apparently, they cannot be used for that purpose. The observed 
changes in Rh-123 uptake are still modest (~3 fold) when compared to the typically 
observed (and/or predicted) 10 fold increase between normal and tumor cells. In addition, 
the morphology of CV-1 cells change continuously upon exposure to media #2, making it 
difficult to clock experiments so that all comparisons are made with cells showing the 
same morphology.  
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4. Conclusions 
In this study we have performed a systematic evaluation on (i) how, and to which 
extent, the molecular structure of a series of rhodamine dyes affects the IR spectroscopic 
properties and fluorescence quantum yields, (ii) how molecular structure and charge 
affects the selectivity with which these dyes localize in energized mitochondria, and (iii) 
the extent to which substrate availability affect both cell morphology and dye uptake 
when using CV-1 cells as a model non-transformed cell line. Here, we have determined 
which structural modifications have the greatest impact on the fluorescence quantum 
yields of these dyes as well as the effect that these modifications have on mitochondrial 
localization. We have also determined that the availability of glucose or glutamine alone 
has a direct correlation on cellular morphology in CV-1 cells. Furthermore, we have 
observed that the stimulation of the anaplerotic pathway of glutaminolysis leads to a 
more pronounced increase in Rh-123 uptake as compared to Rh-110 uptake. These last 
experimental results provide an initial line of evidence suggesting that the mitochondrial 
transmembrane potential of normal (non-transformed) cells can be significantly affected 
by the composition of the media used to grow the cells.   
First, our experimental results have indicated that there is a direct correlation 
between the molecular structure of our selected rhodamine dyes and their respective 
spectroscopic properties and fluorescence quantum yields. We have observed that there is 
a slight decrease in the fluorescence quantum yields as well as a small red shift in the 
wavelength of maximum dye absorption and the wavelength of maximum fluorescence 
emission upon the alkyl substitution of the carbonyl group of the respective free acid dyes 
(Rh-110, Rh6gFA, and RhB). In the same manner, it was observed that there was a 
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modest increase in the fluorescence quantum yields as well as a small blue shift in the 
wavelength of maximum dye absorption and the wavelength of maximum fluorescence 
emission upon the removal of the alkyl group from the ester linkages (Rh6gFA, RhBEE). 
In addition, our experimental results indicate that the fluorescence quantum yields 
decrease upon the increasing degree of alkylation of the amino groups of the respective 
parent dyes.  Moreover, the substitution of bromine atoms of the rhodamine dyes, Rh-123 
and Rh-Oct, results in a characteristic red shift in the wavelength of maximum absorption 
and the wavelength of maximum fluorescence as well as a significant decrease in the 
respective fluorescence quantum yields.  
Second, we have addressed how molecular structure and charge affect the 
selectivity with which our selected rhodamine dyes localize in energized cell 
mitochondria. Here, our experimental results confirm the cationic requirement of 
rhodamine dyes for rapid and effective mitochondrial localization. In addition, we were 
able to confirm that the lipophilic character associated with our selected rhodamine dyes 
was low enough to preclude any competitive phenomenon of lipophilic partitioning on 
subcellular localization. Furthermore, our results indicate that any cationic (and cationic 
only) analog of the ideal mitochondrial localizing dye, Rh-123, (showing appropriate 
lipophilicity) is likely to localize in the energized cell mitochondria of CV-1 cells with 
great specificity. Therefore, any PDT agent with structural features and lipophilic 
character comparable to that of the prototypical cationic mitochondrial marker, Rh-123, 
should also localize in energized cell mitochondria with great specificity and 
subsequently induce targeted cell kill with a high degree of selectivity.   
 Lastly, we have explored the extent to which distinct energy substrate availability 
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in the cell culture media affects both cell morphology and dye uptake when using CV-1 
cells as model normal (non-transformed) cells. Our experimental results indicate that 
optimal amounts of the main energy substrates, glucose and glutamine, are needed in 
combination for long-term growth and proliferation in CV-1 cells. We have observed that 
when either glucose or glutamine is limited, CV-1 cells display abnormal changes in 
cellular morphology and a decrease in cellular proliferation over long time periods. 
Moreover, our experimental results indicate that the change in cellular morphology 
observed when the supply of glucose is limited is reversible when the supply of glucose 
is restored. In addition, we have demonstrated that when the anaplerotic pathway of 
glutaminolysis is stimulated, there is a preferential increase in Rh-123 uptake as 
compared to Rh-110 uptake. The larger dye uptake effects observed for the cationic 
rhodamine (Rh-123) represents a first line of evidence suggesting that mitochondrial 
transmembrane potentials may be significantly affected by glutaminolysis when the cells 
experience glucose starvation.     
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